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ABSTRACT 
DATA MINING AND ANALYSIS OF LUNG CANCER DATA 
Guoxin Tang 
September 24,2010 
Lung cancer is the leading cause of cancer death in the United States and the 
world, with more than 1.3 million deaths worldwide per year. However, because 
of a lack of effective tools to diagnose Lung Cancer, more than half of all cases 
are diagnosed at an advanced stage, when surgical resection is unlikely to be 
feasible. The main purpose of this study is to examine the relationship between 
patient outcomes and conditions of the patients undergoing different treatments 
for lung cancer and to develop models to predict the mortality of lung cancer. 
This study will identify the demographic, finance, and clinical factors related to 
the diagnosis or mortality of Lung Cancer to help physicians and patients in their 
decision-making. 
We combined Text Miner and Cluster analysis to identify the claim data for Lung 
Cancer and to determine the category of diagnosis, treatment procedures and 
medication treatments for those patients. Moreover, the claims data were used to 
define severity level and treatment categories. Compared with using diagnosis 
v 
codes directly, the combination of text mining and cluster analysis is more 
efficient and captures more useful information for further analysis. In order to 
analyze the mortality of Lung Cancer, we also found that survival analysis is 
appropriate to preprocess the data for the relationship between a predictor 
variable of interest and the time of an event. The proportional hazard model 
examined the effects of different treatment clusters using a hazard ratio and the 
proportional effect of a treatment cluster (treatment procedure or medication 
treatment) may vary with time. A decision tree was built to generate rules for 
identifying high risk lung cancer cases among the regular inpatient population. 
Two primary data sets have been used in this study, the Nationwide Inpatient 
Sample (NIS) and the Thomson MedStat MarketScan data. Kernel density 
estimation was used for NIS to examine the relationship between Age, Length of 
stay, Diagnosis Categories, Total Cost and Lung Cancer by visualization. The 
Kaplan-Meier method and Cox proportional hazard model are used for the 
Medstat data to discover the relationship between the factors and the target 
variable for more detail. Time series and predictive modeling are used to predict 
the total cost for hospital decision making, the mortality of Lung cancer based on 
the historical data and to generate rules to identify the diagnosis of Lung cancer. 
Older patients are more likely to have lung cancers that would lead to a higher 
probability of longer stay and higher costs for the treatment. Within 7 defined 
vi 
clusters of diagnosis for Lung Cancer, the malignant neoplasm of lobe, bronchus 
or lung is under higher risk. Age, length of stay, admit type, clusters of diagnosis, 
and clusters of treatment procedures and Major Diagnostic Categories (MDC) 
were identified as significant factors for the mortality of lung cancer. 
vii 
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CHAPTER I INTRODUCTION 
Cancer researchers, clinicians and public notice are dedicated to develop or 
improve statistical models to predict the occurrence or the mortality of some 
cancers. Many risk prediction models have been developed for chronic disease 
since 1976[1]. People are more and more interested in the development of 
individual risk assessment methods of lung cancer, which also has been 
identified as an area of extraordinary opportunity by the National Cancer Institute. 
However, very few models have been developed to estimate the risk of lung 
cancer so far, in contrast to more prevalent modeling in the breast and certain 
other sites[2]. 
Cancer predictive models were applied to design, plan, and establish eligibility 
criteria for cancer intervention and screening trials that also have been used to 
identify individuals at high risk of cancer who may benefit from targeted 
screening or other interventions such as tamoxifen chemoprevention [3]. Cancer 
predictive models are also used to examine the population distribution, the cost 
and the impact of interventions. They are used in clinical decision making to help 
physicians and patients determine the current stage of the cancer and 
appropriate screening regimens, medication, and/or interventions [3]. 
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In addition, personalized medicine will play an important role in the treatment of 
Lung cancer in the next few years. Recent advances in drug development, 
pharmacogenomics, and the molecular characterization of tumors have brought 
the opportunity for individualized selection of treatment based on the 
characteristics of the patient and the tumor. As a genetic disease, it is useful to 
know how many genes are altered in solid tumors associated with Lung Cancer. 
With the advances in massively parallel sequencing technologies, new cancer 
genomes are being sequenced at an astonishing rate. As more cancer genomes 
are sequenced, it will be possible to identify new genes and key mutations [4] [5]. 
However, as Anirban Mahapatra mentioned, molecular characterization of lung 
cancer tumors will continue to be difficult because of the heterogeneity of the 
constituent cells [5]. 
The main purpose of this study is to investigate the relationship between the 
demographic factors, finance, clinical conditions and the diagnosis of Lung 
Cancer. Specific lung cancer risk prediction models based on available variables 
were developed, evaluated and used to predict the cost and mortality for the 
patients and to build rules for identifying diagnoses of Cancer, which will identify 
high-risk individuals and help the physician's clinical decision making. 
This research focuses on the Inpatient Sample (NIS) (inpatient claims only)[6] 
and Medstat MarketScan Databases (Inpatient, outpatient, and pharmacy claims) 
[7]. The NIS database includes five years of data, 2000- 2004, and about 8 
2 
million records for each year. The Thomson MedStat MarketScan data containing 
all patient claims for 40 million people followed for the years 2000-2001. We use 
publicly available data throughout this study. 
Each observation includes fifteen columns of Diagnosis codes and fifteen 
columns of Procedure codes in these data sets. One inpatient admission consists 
of one or more observations. It is possible that there are multiple admissions for 
one patient. Here, any diagnosis or procedure code can appear in anyone of the 
fifteen columns. In order to identify the claims for Lung cancer, we work with all 
fifteen columns to bring all of them into one column as a string of codes, using 
the CATX function, which concatenates character strings, removes leading and 
trailing blanks, and inserts separators. 
This dissertation is divided into nine chapters. In chapter 2, the background and 
current status of lung cancer in the world and USA will be explored as well as 
how Lung Cancer has been staged, which shows the severity level of the cancer 
and the survival rate for each stage. In chapters 3, 4, 5 and 6, we will give some 
background, concepts and theories for data mining, cluster analysis, survival 
analysis, time series and predictive modeling, respectively. In chapter 7, some 
methods mentioned above will be used to analyze the Nationwide Inpatient 
Sample (NIS) database. Lung Cancer claims data will be identified by using the 
Text Mining methodology and Kernel Density Estimation (KDE procedure), which 
was used to examine the relation of lung disease by Age, Length of Stay and 
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Total Charges. Then, cluster analysis will be used to define diagnosis categories. 
Furthermore, an ARIMA model with inflation rate as the dynamic regressor and a 
logistic regression model will be used to predict the cost and mortality of lung 
cancer, respectively. In chapter 8, survival analysis and predictive modeling will 
be applied to the Medstat MarketScan Databases and the four main treatment 
procedures will be defined. Also, a Cox Proportion Hazard Model gives us the 
hazard ratio of each variable to explain how it relates to the mortality of Lung 
Cancer. Then, Decision trees give us the rules for identifying Lung Cancer for 
reference and the Neural Network model is optimal for the prediction of the 
mortality of lung cancer. Chapter 9 concludes and summarizes all the findings. 
4 
CHAPTER II BACKGROUND 
2.1. Lung Cancer 
At the end of the 20th century, lung cancer had become the first worldwide 
cancer in deaths and the number is rising every year. Lung cancer was a rare 
disease at the beginning of that century. Table 2.1 shows the estimated number 
of cases and deaths for 26 different types of cancer in men and women together 
with the age, standardized incidence and mortality rates and the cumulative risk 
(%) between ages 0 and 64 during 2002. Lung cancer is the main cancer with 1.5 
million cases and 1.18 million deaths in the world yearly [8]. 
There were 1.35 million new cases of lung cancer, which was about 12.4% of all 
new cancers. Furthermore, at the beginning, more than half of the cases 
occurred in the developing countries of the world; now it is estimated that 69% 
were in developed countries since 1980. It is the most common cancer for men, 
with the highest rates observed in North America and Europe. For women, the 
incidence rates are lower compared to men (globally, the rate is 12.1 per 100,000 
women compared with 35.5 per 100,000 in men). The highest rates for women 
are in North America and Northern Europe. (D. Max Parkin, Freddie Bray, Global 
Cancer Statistics, 81) [8]. 
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Table 2.1 Incidence and Mortality by Sex and Cancer site worldwide, 2002 
Incidence Mortality 
Males Females Males Females 
Cases Cases Cumulative Deaths Cumulative Deaths Cumulative 
risk(age 0-64) riSk(age 0-64) risk(age 0-64) 
Oral Cavity 175,916 0.4 98,373 0.2 80,736 0.2 46,723 0.1 
Nasopharynx 55,796 0.1 24,247 0.1 34,913 0.1 15,419 0.0 
Other 106,219 0.3 24,077 0.1 67,964 0.2 16,029 00 
pharynx 
Esophagus 315,394 0.6 146,723 0.3 261,162 0.5 124,730 0.2 
Stomach 603,419 1.2 330,518 0.5 446,052 0.8 254,297 0.4 
Colon/rectum 550,465 0.9 472,687 0.7 278,446 0.4 250,532 0.3 
Liver 442,119 1.0 184,043 0.3 416,882 0.9 181,439 0.3 
Pancreas 124,841 0.2 107,465 0.1 119,544 0.2 107,479 0.1 
Larynx 139,230 0.3 20,011 0 78,629 0.2 11,327 0 
Lung 965,241 1.7 386,891 0.6 848,132 1.4 330,786 0.5 
Melanoma of 79,043 0.2 81,134 0.2 21,952 0 18,829 0 
Skin 
Breast 1,151,298 2.6 410,712 0.9 
Cervix uteri 493,243 1.3 273,505 0.7 
Corpus uteri 198,783 0.4 50,327 0.1 
Ovary 204,499 0.5 124,860 0.2 
Prostate 679,023 0.8 221,002 0.1 
Testis 48,613 0.1 8,878 0 
Kidney 129,223 0.3 79,257 0.1 62,696 0.1 39,199 0.1 
Bladder 273,858 0.4 82,699 0.1 108,310 0.1 36,699 0 
Brain,nervou 108,221 0.2 81,264 0.2 80,034 0.2 61,616 0.1 
s system 
Thyroid 37,424 0.1 103,589 0.2 11,297 0 24,078 0 
Non-Hodgkin 175,123 0.3 125,448 0.2 98,865 0.2 72,955 0.1 
lymphoma 
Hodgkin 38,218 0.1 24,111 0.1 14,460 0 8,352 0 
Disease 
Multiple 46,512 0.1 39,192 0.1 32,696 0.1 29,839 0 
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Incidence Mortality 
Males Females Males Females 
Cases Cases Cumulative Deaths Cumulative Deaths Cumulative 
risk(age 0-64) risk(age 0-64) risk(age 0-64) 
myeloma 
Leukemia 171,037 0.3 129,485 0.2 125,142 0.2 97,364 0.2 
2.2 The Causes of Lung Cancer 
The etiology of Lung cancer is still not completely clear, and a large amount of 
data show that lung cancer risk factors include smoking, asbestos, radon, arsenic, 
ionizing radiation, halogen alkene and polycyclic aromatic compounds, nickel, etc. 
Cigarette smoking is a well-established cause of lung cancer. Carcinogens are 
released when burning cigarettes. Long-term smoking can cause a phosphorus 
shape of bronchial epithelium cells, which leads to squamous cell carcinoma or 
undifferentiated small cell carcinoma. Among those patients who did not smoke, 
the adenocarcinoma are more common than lung cancer. In fact, an estimated 
87% of all lung cancers can be attributed to cigarette smoking alone [9]. Although 
smoking is by far the leading cause of lung cancer, the disease has several other 
causes. Lung cancers are still directly or indirectly related to tobacco use from 
cigars, pipes, and secondhand cigarette smoke, but several other risk factors act 
independently or synergistically with tobacco to cause lung cancer. Occupational 
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and environmental exposures, such as asbestos, arsenic, secondhand smoke, 
and radon also increase the risk of lung cancer. 
2.3. Diagnosis and Staging of Lung Cancer [10] 
There are no specific symptoms in the early stage of lung cancer, only for 
general respiratory diseases with symptoms such as cough, phlegm with blood, 
low fever, chest pain, etc, which are often ignored. Here, we list some symptoms 
that occur during advanced stages of lung cancer. 
a) The edema of face or neck. 
b) Hoarse voice, a common symptom. 
c) Difficulty in breathing. 
It easily causes metastases for Lung cancer. If it metastasizes to the brain, it 
would cause a persistent headache, which is not obviously different from ordinary 
tension headaches. If the cancer metastasizes to the bone, it will cause damage 
to the bone. The most difficult cancer metastasis is to the spine, which follows 
with back pain. 
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a) Methods of Diagnosis 
What method of diagnosis of suspected lung cancer should be applied depends 
on the type of lung cancer, the size and location of the primary tumor, the 
presence of metastasis, and the overall clinical status of the patient. 
In order to detect and diagnose lung cancer, the routine disease history and 
physical examination is the important first step, which might provide some signs 
of the cancer. The patient's symptoms that include observing possible indicators 
as discussed above could also carry information about the possibility of lung 
disease[9]. 
Here, we list the several available methods applied to detect lung disease 
(Information is from Thompson Cancer Survival Center) [9][10]. 
• Diagnostic Imaging 
The first step in determining whether a mass is cancer or benign is a 
diagnostic image . 
• X-Ray 
X-ray examination is the most common cancer diagnosis method. 
The X-ray examination can detect the position and size of the 
potential lung masses, but cannot determine if they are cancerous 
or benign. For early lung cancer cases, x-rays cannot detect small, 
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potential tumors, but can show a partial obstruction due to the 
bronchial emphysema, atelectasis or adjacent parts of the lesion. 
• CT Scan 
CT stands for computerized tomography scan, which is a series of 
X-rays combined by a computer in a cross-sectional view and can 
provide a more-detailed image of the lung compared with X-rays. It 
is performed with injected contrast material to highlight lung tissue 
and suspicious masses . 
• MRI 
Magnetic resonance imaging (or MRI) scans use magnetism, radio 
waves and computer image manipulation to produce an extremely 
detailed image without radiation. Compared to the CAT scan, there 
is no damage to the human body since an M~I does not use X-rays. 
The MRI can provide imaging for soft tissue based on multiple 
planes, which the CAT scan cannot match. There are many 
imaging methods and parameter selections for MRI that make more 
applications for the MRI. Changing the radio frequency of pulse, 
repetition of program and echo time will change the imaging. 
• Biopsies 
Biopsies are procedures where a small amount of a suspicious mass is 
removed for examination. There are three main types of biopsy for 
suspected lung masses(Thompson Cancer Survival Center) [9]: 
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• Surgical 
A surgical biopsy is a procedure of gaining a small sample of a 
suspected mass. For such purposes, the patient's chest needs to 
be opened, and then the sample is analyzed by a pathologist. 
• Bronchoscopy 
From the patient's mouth or nose, a bronchoscope is inserted to the 
suspected area, passed through the trachea and bronchial tubes. 
Through this method, the physician could examine the lung mass to 
determine the stage of lung cancer. Usually, there is a sampling 
device to gain a small sample of the suspected mass for analysis. 
• Needle Aspiration or Core Biopsy 
In needle aspiration, a thin needle is inserted into the suspected 
mass and a small sample was gained for analysis. 
• Sputum cytology 
In sputum cytology, the patient's sputum was examined by a pathologist 
under a microscope. The cancer cells can be found in most primary lung 
cancer patients' sputum. Therefore, the phlegm cytology is a simple and 
effective method for lung cancer diagnosis. 
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b) Lung Cancer Staging 
Lung Cancer Staging is the evaluation or measurement of the size and spread of 
a lung cancer. Different lung cancer treatments are used at various stages of the 
cancer. For example, the early stage of cancer can be treated surgically while 
higher stages of cancer use chemotherapy and radiation in a combined therapy. 
The treatment and prognosis of the patients with lung cancer in general may 
depend largely on the stage and cancer cell types. There are two main types of 
lung cancer cell by the size and appearance of the malignant cells. The stage 
systems for non-small cell lung carcinoma (NSCLC) and small-cell lung 
carcinoma (SCLC) are different. 
Lung cancer can be divided into four stages for NSCLC [9][11].(Thompson 
Cancer Survival Center) 
1) NSCLC stage I 
The cancer is small and it has not spread into any lymph nodes or any 
other part of the body. 
2) NSCLC stage /I 
The cancer is in the chest area. However, it has spread into some other 
areas such as the chest wall, the muscle under the lung, or the 
phrenic, or the layers that cover the heart. 
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3) NSCLC stage 11/ 
The cancer is still in the chest area, and the tumors are larger and more 
invasive. Furthermore, it has spread into lymph nodes on the opposite 
side of the chest. 
4) NSCLC stage IV 
The cancer has spread to other parts of the body, such as the liver, bones 
or has caused a fluid collection around the lung or heart that contains 
cancer cells. 
The following figure shows the two year relative survival rate for each stage we 
discussed above. 
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2.4. Treatment of Lung Cancer 
Nowadays, there are several treatments for Lung Cancer as follows. 
• Surgery 
The most common treatment is Surgery. It could be used to remove those 
tumors for the patient in stages I and II. It also could be used for removal 
of a lung lobe or the entire lung. However, it is seldom used on small cell 
lung cancer because the disease has usually spread beyond the lung by 
the time it is detected and diagnosed. 
• Chemotherapy 
Chemotherapy is a chemical treatment which could be used for both the 
non-small cell and small cell lung cancers. 
• External Radiation Therapy 
CT is used to identify the location of the tumor, which could be applied 
before the treatment is scheduled or at the time of treatment. On 
subsequent visits, the tumor is radiated from different angles to maximize 
the dose delivered to the tumor with minimum impact on surrounding 
healthy tissue. 
14 
• Photodynamic therapy 
Photodynamic therapy is used for patients to limit side effects and to keep 
healthy lung tissue in the outpatient. However, it has not been used widely 
because it cannot penetrate deeply into the lung tissue. 
2.5. The distribution of Lung Cancer in US 
Lung cancer is a devastating disease. Not only is it the most common cancer in 
the United States and in Kentucky, it also claims more lives than any other 
cancer. 
Kentucky's lung cancer mortality rate is the highest of all states in the nation. The 
American Cancer Society estimated that in the year 2000, lung cancer accounted 
for 14% of all newly diagnosed cancers and 28% of all cancer deaths, killing 
more than 150,000 people. In Kentucky alone, more than 3,000 people die from 
lung cancer every year. 
Kentucky has distinct geographic and lifestyle regions (e.g., western Kentucky 
differs substantially from eastern Kentucky, just as the state's rural areas tend to 
differ from its urban ones). Each region has different lung cancer rates. Figure 
2.3 shows lung cancer incidence rates across Kentucky's 15 Area Development 
Districts for the period 1994-98. The highest rates are clustered in the Big Sandy, 
Kentucky River and Cumberland Valley Districts[13]. 
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Figure 2.2 Age-adjusted lung cancer incidence rates (cases per 100,000 people) 
by Area Development District in Kentucky, 1994 -98 (Source: Kentucky Cancer 
Registry) . Here, the color of light gray represents rates less than 80, the color of 
gray represents rates between 80 and 85.5, the color of light black represents 
rates between 85.5 and 90 and the black is the rate greater than 90 [13]. 
O'--___ --J 
2.6. ICD9 Codes 
The International Statistical Classification of Diseases and Related Health 
Problems (most commonly known by the abbreviation ICD) introduced the ICD9 
codes to classify diseases, also including a variety of signs, symptoms, abnormal 
findings, complaints, and so on. Every health condition can be assigned to a 
unique category with up to six characters . Such categories can include a set of 
similar diseases that can be converted to a diagnosis. 
The ICD 9 code of 162 means malignant neoplasm of trachea, bronchus, and 
lung. Below are all of the 4-digit codes associated with lung diseases [14]. : 
16 
162.0 Trachea (Cartilage of trachea, Mucosa of trachea). 
162.2 Main bronchus (Carina, Hilus of lung). 
162.3 Upper lobe, bronchus or lung. 
162.4 Middle lobe, bronchus or lung. 
162.5 Lower lobe, bronchus or lung. 
162.8 Other parts of bronchus or lung (Malignant neoplasm of contiguous or 
overlapping sites of bronchus or lung whose point of origin cannot be 
determined). 
162.9 Bronchus and lung, unspecified. 
The data sets we used to analyze in this paper all include ICD9 codes and DRG 
codes (Diagnosis-Related Group); however, DRG codes are based on ICD9 
diagnosis codes, procedure codes, some patient demographic factors and the 
presence of complications or co-morbidities. Hence, we just use the ICD9 code 
to identify the lung cancer population. 
2.7. Summary 
The most important reason that Lung cancer is the leading cause of cancer 
deaths is that the symptoms of lung cancer are very often lacking or occur only 
late in the course of the disease. The prognosis of Lung cancer patients is very 
dependent on how advanced their disease is and what type it is. Developing 
better methodologies for distinguishing between lung cancer and other lung 
17 
diseases or diagnosing early in the course of the disease will help us offer 
greater hope for patients. 
In this dissertation, we will examine the relationship between all the factors for 
the lung cancer population. Several clusters for diagnosis, treatment procedures 
and medications will be defined based on different severity levels. 
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CHAPTER III DATA MINING AND TEXT MINING 
3.1. Data Mining 
The purpose of this chapter is to introduce data mining and text mining concepts, 
the general data mining process, and the most commonly used data mining 
techniques. 
Data mining is one of the fastest growing fields developed with artificial 
intelligence and database technology in recent years. Its core function is to 
extract useful information from huge data sets or a data warehouse and to deal 
with various complex data. Data mining is the process of selecting data, 
exploring data and building models using vast data stores to uncover previously 
unknown patterns [15]. As advanced information processing technology, the 
distinction between data mining and traditional data analysis is that it is a data 
discovery process, and in most cases, there is no hypothesis or a premise 
condition. Data mining can be used for market analysis, risk analysis, defect 
analysis and management, and so on. 
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3.2 Data Mining Process 
Data mining is an iterative process that typically involves the following steps 
displayed in Figure 3.1, which also shows the phases of the Data Mining 
standard process[16] . 
Figure 3.1. General data mining process 
DATA MINING PROCESS 
I Business Goal r ····_· __ ·_·! 
i 
Data 
~···-····"·· ·· I Preprocessing , 
i 
/.. Model Development ~ ......... j 
\( Pattern Discovery 
: 
L; i 
r 1. Unsupervised: • Validation " ·'··"··'···-1 • PCA, FA, DCA, ... i 
2. SUpervised 
Interpretation MlR, lR, NN,Tree, .. 
Decision Making 
Step Identification of Problem and Defining the Business Goal 
Identification is the initial step in the modeling process. This step determines 
what the goal of the model will be. Usually, this step begins with an 
understanding of the nature of the problem and how a predictive model may aid 
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in solving the problem. The business goal is the main target of data mining, and 
determines the main direction and the process of data mining. With well-identified 
problems and a clear definition of the business goal, data mining will lead to 
measurable outcomes. 
Step Data Preprocessing 
Data processing is generally considered the most important and time intensive 
step in the modeling process. The variable data preprocessing and variable 
selection step involves selecting the appropriate variables to include in the model. 
That is, the key to successful data mining is to use the appropriate data where 
some methods are used to distinguish the valuable information to collect, 
eliminate redundant data, and reduce some of the noise or random variation in 
the data. Often, this step involves substantial data transformation in order to set 
up the data so that it is used in the model in the most effective manner. Generally, 
data processing should also include data cleaning and data preprocessing. This 
cleaning and preprocessing is defined as modeling data preparation, including 
data sampling and data transfer, and dealing with missing data. Sampling is 
applied in extremely large databases because it significantly reduces the model 
training time. Additional data are generally separated into several parts; some of 
the data are used to train the model, while others are used to test and to validate 
the model. Data conversion is used to guarantee the quality and availability of 
data. For example, for some predictive models, the data need to be discrete and 
normalized from continuous data. 
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Step Model Development! Pattern Discovery 
Many different types of data mining technology and modeling techniques, such 
as classification, clustering, regression, neural networks, and decision trees are 
employed to highlight previously hidden relationships amongst the data. 
a) Classification analysis: discovery of a predictive learning process 
that classifies important and relevant information into one of several 
predefined classes. 
b) Clustering analysis: Cluster analysis is a set of methodologies for 
automatic classification of samples into a number of groups using a 
measure of association, so that the samples in one group are 
similar and samples belonging to different groups are not similar 
[17] .. In the process, clustering analysis is to identify a finite group 
of clusters to describe the entire data. 
c) Time series analysis and forecasting: Time series analysis, similar 
to correlation analysis, whose purpose is to find the inner relation 
between data values, comprises methods that attempt to 
understand the underlying context of the data, measured typically 
at successive times, or to make predictions. 
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Step Model Validation 
Once the model is built using the training data sample, the model is subjected to 
validation by independent datasets, which is an important requirement in data 
mining. This step involves evaluating the model and deciding if the model was 
successful both in determining which variables are the predictors, and the degree 
of confidence in selecting the variable the model demonstrates. If multiple 
models were developed, the models are evaluated together and the best model 
is typically chosen. 
Step Interpretation and Decision Making 
Data mining models are used to help in decision making. Usually, the simple 
models are more interpretable; the results of the model are used to develop a 
series of "rules" used for decision-makingand specific techniques are needed to 
validate the results to interpret the high-dimensional models. 
3.3. Text Mining 
Text Mining is a technology for discovering and extracting information from a 
wide variety of unstructured text documents in a collection by uncovering any 
themes and concepts that are contained in the collection [18]. Text Mining 
consists of many technologies such as information retrieval and information 
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extraction, natural language processing and data mining technology. It is a 
multidisciplinary mixed area. It cooperates with information technology, text 
analysis, statistics, pattern recognition, data visualization, database technology 
and machine learning. 
Text mining can give a general understanding of the documents as shown in 
Figure 3.2. It has the following components: the bottom part represents the base 
areas of Text mining, including machine learning, mathematical statistics, and 
natural language processing. The middle part introduces the basic text mining 
technologies of text extraction, classification, clustering, text data compressing 
and processing. Based on those two parts, the top one is the application for text 
mining, including information access and discovery. Information access includes 
information retrieval, filtering, and reporting. Information discovery includes data 
analysis and data prediction. 
Figure 3.2 The concept and technologies of Text Mining [18]. 
Information access, Information discovery 
r r r r r 
Text Text Text Text data Text data 
Extraction Classification Clustering compressing Processing 
r r r r r 
Machine learning. statistics. natural language processing 
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In order to apply text mining methods, text needs to be broken into components 
such as words, phrases, multiword terms, entities, punctuation marks, and terms 
in foreign languages. Here, a multiword term is defined as a group of words to be 
processed as a single term and entities include items such as names, addresses, 
companies, and measurements [19]. 
3.4 Dimension Reduction 
Because text mining is always applied to extract useful information from 
unstructured text documents, which are multivariate, it is difficult and time-
consuming to use the entire data (including all the terms). A term-document 
frequency matrix is generated by paring the document collection. The rows and 
columns represent the terms and documents, respectively. Each entry of the 
matrix is the number of times that a term appears in a document. Dimension 
reduction will be necessary and applied to improve the model performance and 
efficiency with high dimensional data. Here, we introduce singular value 
decomposition, which will be used in this paper. 
Singular Value Decomposition (SVD) is a proven mathematical method that 
defines concepts by projecting each document into a reduced dimensional space. 
The more similar documents will be closer in the reduced space; on the other 
hand, the more dissimilar documents will be farther in the reduced space. This is 
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the main idea that SVD explains. The following is the mathematical definition for 
SVD. 
The SVD of matrix G, the sparse term-by-document frequency matrix having n 
documents and P terms, is defined by the equation [20]. 
where the columns of U are orthogonal eigenvectors of GG
1 
, the columns of V 
are orthogonal eigenvectors of GIG, and L is a diagonal matrix of singular 
values, which are the square roots of the eigenvalues of GG
I
. For SVD 
reduction, the matrix G consists of columns of V that correspond to the largest 
singular values. Rows of U are the number of terms and rows of V are the 
number of documents [19]. 
l' r 
To get the SVD values, we need to calculate V and L by using G G. 
and 
U = GJIL,-I 
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3.5 Clustering 
In order to use the clustering analysis, the documents need to be represented 
and reduced as concepts in multidimensional space. In classification, the 
category structure is known, and in cluster analysis, the category structure is 
unknown. The objective in this case is to discover a category structure based on 
the data (observations). 
There are two clustering techniques in Text Mining. One method uses a 
hierarchical clustering algorithm where each document is placed in a specific 
sub-tree. The other method uses the expectation-maximization (EM) algorithm, 
which approximates the observed distributions of values based on the 
combination of different distributions of different clusters. 
• The expectation-maximization (EM) algorithm for clustering [19] 
Assume there are k clusters with density functions J;, i = 1,2, .... k , and there are 
n variables in the data set. Then the mixture model probability density function at 
point x is: 
k 
P(x) = I w,/;(x I U"L,) 
,~I 
where w, is the proportion of data that belong to cluster i, and u, and L, are the 
mean vector and covariance matrix for cluster i . 
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For each cluster, the n dimensional Gaussian distribution is 
1 1 1-1 
f,(XIU"L,)= ~ exp(--(x-uJ (L,) (x-u,)) 
(2nf I L, I 2 
The expectation-maximization clustering is a process which has the following 
basic steps: 
1: Obtain initial parameter estimates. 
2: Apply the standard EM algorithm to find new clusters. 
3: Update parameter estimates. 
4. Repeat step 2 and 3 until the cluster membership stabilizes. 
For each observation x in the data set at iteration j , the parameter estimates of 
the standard EM algorithm are computed as follows [19]. 
1. Compute the membership probability of x in each cluster h = 1, ... , k . 
Wi .(' (x I uJ "J ) 
Wh(x) = h.lh h'~h 
I w/f,(x I u/ ,I: ) 
2. Update mixture model parameters for each cluster h = 1, ... , k . 
wh+ 1 = I wh (x) 
L wi (x)x L wi (x)(x - ui+ 1 )(x - uti f 
j+1 x ~J+l = x 
U h = ~ ~------==-------------L wi (x) h L wi (x) 
x x 
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The iterative process stops if 
where Ii > 0, and 
The EM clustering algorithm computes the probabilities of clusters according to 
the probability distributions, instead of maximizing the difference in mean for the 
variables by assigning observations to clusters. And the EM algorithm could be 
used for categorical or continuous variables. 
3.6 Summary 
Data mining is a powerful technology to extract information from the huge 
potential of unknown and potentially useful information from large databases. 
With this strong analysis technique, the original raw data are changed into 
valuable information, which may provide a competitive advantage for the 
decision-makers. 
Text Mining uses unstructured textual information and examines it in an attempt 
to discover structure and implicit meanings hidden within the text. SAS Text 
Miner provides a rich suite of tools for discovering and extracting knowledge from 
text documents. It transforms textual data into a usable, intelligible format that 
29 
facilitates classifying documents, finding explicit relationships or associations 
between documents, and clustering documents into categories. 
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CHAPTER IV SURVIVAL ANALYSIS 
4.1. The History of Survival Analysis 
The origin of survival analysis can be traced back to several centuries ago. 
Based on the interest in reliability (or failure time) of military equipment, survival 
analysis developed quickly. At the end of World War II, these newly developed 
statistical methods quickly spread to industry from strict mortality data research 
to failure time research. With the development of survival analysis, 
nonparametric or semi-parametric methods took the place of parametric models 
in dealing with the clinical trials in medical research [21]. 
Next, we introduce several distribution functions in the following sections, which 
are the fundamental tools of survival analysis [22]. 
4.2. The Cumulative Distribution Function [23] 
Suppose a non-negative random variable T denotes the lifetimes of individuals in 
some population. The c.d.f of T, Fr (t), is defined by 
Fr (t) = Pr (T~ t). 
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For example, if T represents the age of first occurrence of a chronic disease, 
then Fr (t) is the distribution of age for the disease. In survival analysis, the 
complementary function is more commonly used, which is denoted as the 
survival distribution function discussed in the following sections. 
4.3. The Probability Density Function 
The p.d.f of T, fr(t), is defined by 
fr(t) = d(F;(t» 
dt 
Here, tr(t) is the absolute instantaneous rate of death (disease). 
4.4. The Survival Function 
The Survival function is the complementary function of the cumulative distribution 
function. Let T ~ 0 have a p.d.f fAt) and c.d.f Fr(t). Then, the survival function 
is denoted by the following form: 
Sdt) = P{T> t} = 1 - Fr(t) = fiT (x )dx 
Conversely, the pdf can be expressed as 
f.(t) = lim Pct ~ T < t + Ill) = dFy(t) = _ dSr(t) . 
I ill 40+ III dt dt 
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4.5. The Hazard Function 
The hazard function h-r(t), which is the relative failure (death) rate at time t is 
given by the following [24]: 
h C ) 
= 1· _P-,,-(t_:::;_T_<_t _+_6_t ,--I T_~~t) 






It is easily verified that hT(t) specifies the distribution of T, since 
hr (t) = _ dSr (I) / dt = _ d log(SrC t )) . 
SrCt) dt 
Integrating hr(u) over (O,t) gives the cumulative hazard function Hr(t): 
which is the inverse function of the exponential function. Thus, 
Hence, the p.d.' of T can be expressed as 
Note that H (00 ) = [h T (t) dt = 00 . 
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The relationship is clear between these functions. The p.d.f is the derivative of 
the c.d.f, and the c.d.fis the integral of the p.d.f. The survival function is simply 1 
minus the c.d.f, and the hazard function is simply the p.d.f divided by the survival 
function [25]. 
4.6. Censoring 
In order to apply survival analysis, the beginning and the end of the study need to 
be carefully defined. For example, for a complete observation in our lung cancer 
study, the survival time may begin on the day a patient is diagnosed with lung 
cancer and end when that patient dies because of the cancer. Here, this patient 
is an uncensored subject, where the event occurs during the time period of 
observation. In a data set, some observations end because of the occurrence of 
the event, and others have no event by the end of the observation period, which 
would be called censored observations. For example, the patient might be still 
alive after five years from lung cancer and do not know when he died or died due 
to an unrelated cause. Therefore, we need some techniques to deal with these 
observations due to different reasons. 
Right censoring is the most common method for dealing with incomplete data. A 
right censored subject is one that is no longer observed before the event 
occurrence. It allows subjects to contribute to the model until they are no longer 
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able to contribute (end of the study, or withdrawal), or they have an event. Figure 
4.1 gives us the basic information about the right censoring method. 
Let T;,~, ... ,Tn be independent and identically distributed n subjects with 
distribution function FT(t) in a study. Notice that some subjects have events early 
during the study period, some have events at the end of the study period and 
others have no event during the entire period. For example, for the patients with 
lung cancer, some died during the observation period and most of them are 
simply right censored at the end. Therefore, we terminate the study at a pre-
specified time t,. (for our case, the end of two years). 
Figure 4.1 Right censoring [24]. 
o 
Let Ie be denoted as the fixed censoring time [24]. Instead of observing the T; , 
we observe ~'Y2' ... 'Yn where 
. {T; r: = mmCT;,/J = 
Ie 
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if T,~ (. 
if te < T; 
A binary random variable 0 is used to denote if an event time is observed or 
censored, 
Note that (0 =0 and T::; Ie) implies that the event time was preciselyT = I" which 
occurs with zero probability if T is a continuous variable. 
With maximum likelihood estimation, the joint likelihood of the pair (Y ,0 ) could 
be calculated as follows. For y < tc , 
P(Y::; y) =P(T ::; y ) =F(y), 
and 
P( £5 = 1 I Y ::; y) = 1. 
Therefore, the likelihood for Y= y < Ie and is =1 is the density f(y). For y = Ie and 
is =0, the likelihood for this event is the probability 
pro =0, y = Ie )=P(T > IJ= S(tJ . 
Hence, the likelihood function for the n independent and identically distributed 
random pairs (Y"o,) is given by [24], 
n 
L = TIf(y, )0, S(tj-O, . 
,~I 
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4.7. The Kaplan-Meier method 
The Survival curve is the graph of the survival function S(t) based on time t. The 
Kaplan-Meier method can be used to estimate this curve from the observed 
survival times without the assumption of an underlying probability distribution [25]. 
Let tidenote an ordered observed value. The empirical survivor function (esf) , 
denoted by Sn (t), is defined to be 
Sn(t)= # of observation> t = # {t, > t} 
n n 
For each of n individuals, the pair (Y"J/) is denoted as follows 
Y, = min(I; , C, ) 
and 
The people at risk of an event at the beginning of the interval Y, are those people 
who survive (no event occurred) the previous interval Y,-l . 
Let R(t) denote the risk set just before time t and let 




=# of event occurred at time Y(I) 
Pi = P(no event through Y, I no event at beginning Y,) 
= peT > Ye,l IT> Y(I-l)) 
q, =1- P, 
=P(event occurred in Y i I alive at the beginning Y , ). 
Recall the general multiplication rule for joint events A1 and Ai 
The survival function can be expressed as 
Set) = peT > t) 
Here, P1 is the proportion surviving the first period, P2 is the proportion surviving 
beyond the second period conditional on having survived up to the second period, 
and so on. 












The K-M estimator of the survivor function is 
Y(I) 
where Y(k) ~ t < Y(k+I)· 
4.8. Cox's proportional hazards model (Cox regression) [24][26] 
The Cox proportional hazard model is the most widely used method in survival 
analysis, especially in medical or clinical studies. It is an extension of the logistic 
regression model with conditions. For example, the baseline hazard function is 
equivalent to the intercept in the logistic regression. 
For the Cox proportional hazards model, the hazard function is 
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h(t I X) = ho(t)· ef3x , 
where ho(t) is an unspecified baseline hazard function, which is estimated at the 
mean values of the variables. Here 
Then we have 
One of the advantages for the Cox hazard model is the non-parametric baseline 
function ho(t). Here, eP' is the hazards ratio, which is assumed constant with 
respect to time t, which is similar to the odds ratio in logistic regression. 
Figure 4.2. The relationship between hazard and survival [24] 
t h(t) 
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If the hazard ratio is less than one, then the ratio of corresponding survival 
probabilities is larger than one. Hence, the treatment group has a larger 
probability of survival at any given time t, after adjusting for the other covariates. 
For any (Proportion Hazard) PH model, the survival function at timet, given a set 
of predictors X is 
S(t I X) = exp( - S: h (u I X ) du ) 
= exp( -exp( PX) rho ( u ) du ) 
= (exp(- f; h 0 (u ) du ))exp( pX) 
=( So (I) ) exp( pX) 
where So(t) denotes the baseline survivor function. The p.d.f. at time t, given a 
set of predictors X is 
lCt I X) = ho(t) exp(pX) (So (t)) exp( pX). 
In Cox's model, there is no assumption about the distribution of the hazard 
except that it is assumed that the hazard ratio does not change over time. 
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4.9. Summary 
The survival curve describes the relationship between the probability of survival 
and time. The Kaplan- Meier method is used to estimate the survival curve from 
all of the observations available. Cox's proportional hazards modeling gives us 
the hazard ratio, which explains the risk of the event for a certain variable. No 
assumptions of parametric distribution for the survival time make Cox regression 
more attractive. Using the partial likelihood function makes the Cox regression 
model more flexible to examine the dependent variables. 
Survival analysis is appropriate for outcomes that occur during follow-up of 
patients. The outcome may be death or another event, such as the recurrence of 
disease in cancer, or a complication after implantation of a heart valve. 
We will be applying Kaplan-Meier method and Cox regression model to examine 
the relationship between the patient demographic factors, the diagnosis, 
treatment procedures and mortality of lung cancer. 
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CHAPTER V TIME SERIES MODELS AND PREDICTIVE MODELS 
5.1. Time Series Models 
A Time series is a set of measurements for a sequence of random events 
according to the time. It is a prediction method using historical time series to 
forecast the future value by statistical analysis and a mathematical model. 
The ordinary regression model is the foundation of time series analysis. The 
independent variables include the lag value from itself and other dependent 
variables, including their lag values. 
There are three basic models for Time Series Models: the autoregressive model 
(AR), moving average model (MA) and autoregressive moving average model 
(ARMA). When regular differencing is applied, The Autoregressive Integrated 
Moving Average Model (ARIMA) is a combined model together with AR and MA 
[27]. 
Let {Y" t ::0 O,± 1,±2, .... } be a time series and {£I' t = O,± 1,±2, ... } be the error (white 
noise) with mean zero and variance(T2, 
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E(&}) = (J2 (5.2) 
with the & 's uncorrelated with time, 
The lh autocovariance of ~ is 
= E(~ - Ut )(~-J -ut_) (5.4) 
where U t is the mean of Y t and fy y y is the joint density function of Y t , p I I'" I-I 
We also define the backward shift operator B here by B~ = ~-1 . We also have 
The backward difference operatorV' , is defined by 
V'~ = ~ - ~-1 = (1- B)Yt • (5.6) 
5.1.1 Autoregressive Model 
The basic assumption for time series models is that the data have an internal 
structure, such as autocorrelation, trend or seasonal variation, which is the 
forecasting methods' purpose. The AutoRegressive (AR) [28] model can be used 
to forecast future values. A pth-order autoregressive, AR(p), model is defined as 
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(5.7) 
where &[ is the prediction error, and (A "." ¢p are the unknown autoregressive 
coefficients. The order of the model tells how many lagged past values are 
included. The simplest AR model is the first-order AR(1). 
Here, AR(p) could be written as the following: 
(1 ~ ¢IB ~ ¢2B2 ~ .. , - ¢pBP)Y( = £( 
¢(B)~ = SI (5.8) 
An AR(p) process is covariance stationary if and only if all roots of its 
characteristic polynomial: 
(5.9) 
lie outside the unit circle. If y = 1 is a solution of the characteristic polynomial 
(5.6), then the process has a unit root. The presence of a unit root causes the 
autocovariances to vary over time. Therefore, for any models with autoregression 
or other stationary methods, the data need to be differenced at the first lag. The 
autoregression model can also be viewed as a special case of the multiple 
regression models, where the independent or predictor variables are the past 
values of the process itself. 
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5.1.2. Autoregressive Moving Average Model 
The moving average (MA) is a model in which the time series is regarded as a 
moving average (unevenly weighted) of a random shock series ct . The moving 
average model of order q, or MA(q) , is given by 
l'r = &/ - 81&/-1 - 82&/-2 - •.• - 8/:it _ q 
= (1- 8
J 
B - ... - 8qBq )£( 
= 8(B)£{ . (5.10) 
where {£t} satisfies (5.1), (5.2) and (5.3) and 8J! 82 , ••• , 8q are the unknown 
coefficients. 
If the parameters of moving average satisfy some certain conditions such that the 
model is invertible, there exists a duality between the moving average process 
and the autoregressive process, which is that the moving average model can be 
rewritten into an autoregressive form. 
Moreover, if combined with AR models, the moving average model and 
autoregressive model form a very powerful tool, the autoregressive moving 
average (ARMA) model. In the ARMA model, the current value of the time series 
Y{ is expressed linearly in terms of its past values and previous values of the 
white noise (error). 
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The autoregressive moving average model of order (p,q), or ARMA (p,q), is 
written as 
where the coefficients are the same as in (5.7) and (5.10). 
or, ARMA (p,q) could be written as in lag operator form: 
(l-¢I B -¢2 B2 - ... -¢pBP)Y, =(l-B1B-B2B
2 
- ••• -B"B'I)c,; 
that is, 
¢( B)Y, = B( B)c( . 
5.1.3. Autoregressive Integrated Moving Average Model 
In the 1970s, Box and Jenkins introduced a general model, autoregressive 
integrated moving average (ARIMA), which contains three parts, autoregressive, 
moving average, and differencing. Specifically, it has three types of parameters: 
the autoregressive parameters ((A " .. , rPp ), the number of differencing passes at 
lag 1 (d), and the moving average parameters (Bp ... , Bq). I n the notation 
introduced by Box and Jenkins, a series that needs to be differenced d times at 
lag 1 and afterwards has orders p and q of the AR and MA components, 
respectively, is denoted by ARIMA(p,d,q) and can be conveniently written as 
47 
(5.12) 
where the V' is backward difference operator, and B is the backward shift 
operator; that is, Bh Xt == Xt- h . Note that ARIMA(p, 0, q) is simply an ARMA(p, q) 
process. 
5.1.4. Model Identification 
Time series modeling of ARMA and related models proceed by a series of well-
defined steps. The first step of this process is model identification to specify the 
appropriate structure (AR, MA, ARMA or ARIMA) and the order of the model. 
The sample autocorrelation function (ACF) and the partial autocorrelation 
function (PACF) plots or a goodness-of-fit statistic or information criterion are 
used to identify or select the best model for prediction. In general, increasing the 
complexity of the model structure, for example, increasing the number of 
variables, just provides an artificial improvement of fitness. 
5.2 Predictive Models 
Multiple linear regression modeling and Logistic regression modeling are all 
regression methods. The difference between them is that the former is designed 
to predict an interval-valued target variable and the latter is designed to predict a 
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categorically-valued target variable. Regression modeling is used to examine the 
relationships between the input variables (independent variables) and the target 
variable (dependent variable) and to determine the best predictors for the target. 
In other words, the objective of regression analysis is to determine the optimal 
balance of choosing the model with the smallest error and the fewest number of 
parameters [29]. 
5.2.1. Logistic Regression Modeling 
Logistic regression models are used to predict the response variable by 
redefining the variable through the use of an indicator variable. Since the 
predicted value is used to estimate the probability of the target event and will not 
result in the desired interval in predicting the probabilities that must be between 
the interval of zero and one, the linear regression should not be applied to the 
categorical target variable[30][31]. 
The logistic regression model is a widely used statistical technique for binary 
medical outcomes. The model is flexible in that it can incorporate categorical and 
continuous predictors, non-linear transformations, and interaction terms. Many of 
the principles of traditional regression also apply for logistic regression. 
In order to obtain the best predictive performance, it is important that the model 
be correctly specified. Correct specification of the model involves selecting the 
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correct set of input variables in the model and the appropriate error distribution 
that matches the range of values of the target variable. However, in logistic 
regression modeling, it is also extremely important to select the correct link 
function that conforms to the range of values of the target variable. 
For k explanatory variables and i = 1,2, ... ,n observations, the model is 
(5.15) 
where p, is the probability for y, = 1. Here, log is the naturallogorithm, a is the 
intercept, and P, are the estimated regression coefficients. 
Unlike the usual linear regression model, there is no random white noise or error 
in the equation for the Logistic model, which does not mean that the model is 
deterministic because of the probabilistic relationship between p, and y,. 
We can solve the logit equation for p" 
p = exp(a + PIX,I + ... + PkX,k) 




5.2.2. Decision Tree 
The goal of decision tree modeling is to identify various target groups based on 
the values from a set of input variables to provide insight into the decision 
process. Each split is performed from the values of one of the input variables that 
best partitions the target values. For categorical target variables, the model is 
called a classification tree, in which the leaves that contain the target proportions 
can be interpreted as predicted probabilities or predicted proportions of the 
categorically-valued target variable. For interval-valued target variables, the 
model is called a regression tree, where the leaves that contain the target means 
can be interpreted as predicted values of the target variable[32]. 
The Standard Decision Tree Algorithms 
The AID, CHAID and CART methods are the most widely used algorithms for 
decision tree modeling [33]. 
Automatic Interaction Detection (AID) was used to fit trees to predict a 
quantitative variable. Stepwise splitting is the foundation of the algorithm. It 
begins with a single cluster and splits this cluster into two or more clusters based 
on some defined rules. Here, each variable is examined for splitting as follows 
[34] : 
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a) Sort all the n observations on the variable and examine all n-1 ways 
to split the cluster into two or more groups. 
b) Calculate the sum of squares about the mean of the cluster on the 
dependent variable for each possible split. 
c) Choose the best of the n-1 splits to represent the variable's 
contribution and repeat for all the variables. 
The CHi-squared Automatic Interaction Detector (CHAID) algorithm is only for 
categorically-valued input variables, and it cannot be used for ordinal-valued 
input variables. 
The Classification and Regression Tree (CART) method is based on statistically 
optimal splitting of the observations into pairs of smaller subgroups. The Gini 
index is used to measure the probability of a randomly selected element would 
be incorrectly labeled if it was randomly labeled based on the distribution of 
labels. Here CART uses the Gini index to measure the impurity at a node, and 
then choose the split to maximize the reduction in impurity [32]. 
5.2.3. Neural Network 
There are many applications of neural networks to industrial applications, 
including predictions of occurrence or cost and target classification. In general, 
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neural networks have several layers with interconnected nodes where each node 
is determined by a non-linear function of the inputs. 
There are three types of nodes. The following Figure 5.1 shows the basic 
information of the feedforward neural network. The input unit represents the input 
variables, where each input variable has its own weights in the input layer. The 
hidden units perform an internal, nonlinear transformation and the output units 
generate the predicted values, and then compute the error that is the difference 
between the predicted values and the values of the output units in the output 
layer. 
Figure 5.1 The diagram for multilayer feed-forward network. 




There are several general kinds of transfer functions commonly used: 
• Identity Function does not change the value of the inputs, which has the 
same range as the inputs. 
• Sigmoid Functions are S-shaped functions such as the logistic and 
hyperbolic tangent functions. 
• Softmax Function is a multiple logistic function. 
• Value Functions are bounded bell-shaped functions such as the Gaussian 
function. 
• Exponential Functions. 
In this paper, the transfer function is given by 
1 
I(x) = 1 -x 
+e 
A big drawback to neural network modeling is that it is very difficult to determine 
the contribution of the input variables to the target variable in the model. Unlike 
traditional regression parameter estimates, the weight estimates do not indicate 
the effect, magnitude or the rate of change in the relationship between the target 
variable and the input variables. 
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5.3 Summary 
Time series analysis is a prediction method using historical time series to 
forecast the future value by statistical analysis and mathematical models, which 
determines if the data taken over time has an internal structure (such as 
autocorrelation, trend or seasonal variation). A predictive model is made up of a 
number of predictors, which are variable factors that are likely to influence future 
behavior or results. These models can be used to help physicians and health 
policy makers in their decision-making on the screening and treatment of disease 
in high-risk patient groups. 
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CHAPTER VI DATA ANALYSIS FOR NIS DATABASE 
6.1 Overview of NIS Data 
The Nationwide Inpatient Sample (NIS) is a powerful database of hospital 
inpatient stays, which includes healthcare cost and utilization. It could be used to 
identify or analyze national trends in health care cost, utilization, quality, and 
outcomes by researchers or decision-makers. 
The NIS contains clinical and resource use information included in a typical 
discharge abstract, with safeguards to protect the privacy of individual patients, 
physicians, and hospitals (as required by data sources). The NIS can be 
weighted to produce national estimates. The new version of NIS contains 
severity adjustment data elements, such as APR-DRGs, APS-DRGs, Disease 
Staging, and AHRQ Co-morbidity Indicators. The Diagnosis and Procedure 
Groups Files are also added to the 2005 version of NIS. Access to the NIS is 
open to users who sign data use agreements. Uses are limited to research and 
aggregate statistical reporting. 
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The NIS is a uniform, multi-state database that promotes comparative studies of 
health care services and will support health care policy research on a variety of 
topics including: 
• Use and cost of hospital services 
• Medical practice variation 
• Health care cost inflation 
• Hospital financial distress 
• Analyses of States and communities 
• Medical treatment effectiveness 
• Quality of care 
• Impact of health policy changes 
• Access to care 
• Diffusion of medical technology 
• Utilization of health services by special populations. 
There is much clinical and nonclinical information for each hospital stay in NIS, 
such as: 
• Primary and secondary diagnoses 
• Primary and secondary procedures 
• Admission and discharge status 
57 
• Patient demographics (e.g., gender, age, race, median income for ZIP 
Code) 
• Expected payment source 
• Total charges 
• Length of stay 
• Hospital characteristics (e.g., ownership, size, teaching status). 
Some of the variables we will work with in the NIS data include patient 
demographics: 
• Age (in years) 
• Female (O=male, 1 =female) 
• Race(1 =White, 2=Black, 3=Hispanic, 4=Asian/Pacific Islander, 5=Native 
American, 6=Other) 
• ORG 
• Patient diagnoses in ICOg codes (OX1-0X15, fifteen columns) 
• Patient procedures in ICOg codes (PR1-PR15, fifteen columns) 
• TOTCHG (Total Charges) 
• LOS (Length of Stay) 
In order to work with these variables, there are some preprocessing issues, 
especially to work with 15 columns of diagnosis and procedure codes. 
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6.2 Data preprocessing 
The lung cancer data are from the NIS, and we had five years of data, 2000 to 
2004. Here, we first put all the five years of data into one data set and create a 
binary variable to label lung cancer according to diagnosis codes. In order to 
simplify the process of discovery, we first concatenate all 15 columns of variables 
into one text string using the CATX statement. This code put all possible 
diagnosis codes into one text string , and defined a second string containing all 
possible procedure codes using the CATX statement. 
To find those patients with Lung Cancer, the RXMATCH function was used. The 
RXMATCH looked for the initial code of '162' that found all patients with a 
diagnosis code related to lung disease. Because '162' can occur in other codes 
that are not related to lung cancer, such as '216.2', we use four digits of code 
rather than three to avoid catching '216.2'. The code used was the following: 
data nis . lungcancer nis OOto04 ; 
set nis . nis OOto04 ; 
lungcancer=O; 
diagnoses=catx( ' ' , dxl , dx2 , dx3 , dx4 , dxS , dx6 , dx7 , dxB , dx9 , 
dxlO , dxll , dx12 , dx13 , dx14 , dxlS) ; 
procedures=catx( ' ' , prl , pr2 , pr3 , pr4 , prS , pr6 , pr7 , prB , pr9 , 
prlO , prll , pr12 , pr13 , pr14 , prlS) ; 
if (rxmatch( ' 1620 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1621 ' , diagnoses» O) then lungcancer=l; 
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if (rxmatch( ' 1622 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1622 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1623 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1624 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1625 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1626 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1627 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1628 ' , diagnoses» O) then lungcancer=l; 
if (rxmatch( ' 1629 ' , diagnoses» O) then lungcancer=l; 
run ; 
Recall that the ICD 9 code of 162 means malignant neoplasm of trachea , 
bronchus, and lung . Below are all of the 4-digit codes associated with lung 
diseases: 
162.0 Trachea (Cartilage of trachea , Mucosa of trachea). 
162.2 Main bronchus (Carina , Hilus of lung) . 
162.3 Upper lobe, bronchus or lung . 
162.4 Middle lobe, bronchus or lung. 
162.5 Lower lobe, bronchus or lung . 
162.8 Other parts of bronchus or lung (Malignant neoplasm of contiguous or 
overlapping sites of bronchus or lung whose point of origin cannot be 
determined) . 
162.9 Bronchus and lung, unspecified . 
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6.3. Data Visualization 
There are a total of 40,363 observations for the five years of data related to lung 
disease out of 3,833,637 records. Note that approximately 1.04% of the inpatient 
population has a diagnosis of lung disease (shown in Table 6.1 and Figure 6.1). 
It is clear that lung cancer is a small sample of patients compared with the total 
size of the data set. 
Table 6.1 The frequency of lung cancer. 
The FREQ Procedure 
Cumulative 
lungcancer Frequency Percent Frequency 
- -
0 3833637 98.96 3833637 
1 40363 1 . 04 3874000 
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The data summary of some of the variables is given in Table 6.2. Note that the 
average age for a patient with lung cancer is about 68, about 21 years more than 
the average age for those without lung cancer. Males have a higher probability of 
having lung cancer compared with females. The patients with lung cancer have 
a higher probability of staying about 7 days in the hospital compared to those 
without lung cancer. Obviously, they also have higher costs. 
Table 6.2 Summary of Age, Gender, Length of Stay and Total Charge 
The MEANS Procedure 
lungcancer=O 
Variable Label Mean Std Dev Minimum Maximum N 
- - -- -----------.- ~-- - -----
AGE Age in years at admi ss i on 47 . 1301216 28 . 2108228 0 123 . 0000000 3831194 
FEMALE Indicator of sex 0. 5937489 0 .4 911326 0 1 . 0000000 3827 460 
LOS Length of stay (cleaned) 4. 5790612 6. 7308 461 0 365 . 0000000 3833334 
TOTCHG Total charges (c l eaned) 17227 . 54 32582 . 70 25 . 0000000 1000000 . 00 3720854 
lungcancer=1 
: 
Variable Label Mean Std Dev Minimum Maximum N 
'AGE Ag. i, y,a" at admi"1,, r67 ' 9667005 11. 3391793 1 . 0000000 105 . 0000000 40361 
FEMALE Indicator of sex 0 . 4484 31 4 0 . 4973397 0 1 . 0000000 4035 4 
I LOS Length of stay (cleaned) 7. 0992591 7 . 5899129 0 316 . 0000000 40359 
, TOTCHG Total charges (cleaned) 26425 . 10 3834 1. 29 40 . 0000000 1000000 . 00 39371 
Data visualization can be used to extract useful knowledge from large and 
complex datasets. The visualization can be used to build a narrative concerning 
the data . Kernel density estimation provides information about the entire 
population distribution rather than to rely on means and variances. Then, the 
Kernel Density Estimation (KDE procedure) was used to examine the lung 
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disease by Age, Length of Stay and Total Charges, which showed the 
relationships among these outcomes by using data visualization . 
First, we use PROC KDE to examine the variables in relationship to the data with 
kernel density. The main advantage of using kernel density estimation is that the 
graphs can be overlaid for more direct comparisons. For example, we consider 
the relationship of lung cancer to Age, Length of Stay and Costs. 
proc sort data=medstat . inpatientadm 
out=work . sortedinpatientadm; 
by lungcancer ; 
proc kde data=work . sor'tedinpatientadm; 
univar age/gridl=O gridu=lOO 
out=medstat . kdeinpatientadmage ; 
by lungcancer ; 
run ; 
proc kde data=work . sortedinpatientadm; 
univar day?/gridl=O gridu=500 
out=medstat . kdeinpatientadmdays ; 
by lungcancer ; 
run ; 
proc kde data=work . sortedinpatientadm; 
univar totpay/gridl=- lOOOOO gridu=300000 
out=medstat . kdeinpatientadmtotpay ; 
by lungcancer ; 
run ; 
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Note that the patients without lung cancer have a relatively constant likelihood of 
an inpatient event regardless of age (except for the interval of 0 to 20 and 60 to 
80 , where there is a slight change. However, patients with lung cancer increase 
inpatient events starting at age 38 , accelerating at age 45, and decreasing at age 
78. 
Figure 6.3 The Density of Lung Cancer by LOS (Length of Stay) using Kernel 
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Those with lung cancer have a higher probability of a stay of 6 or more days, and 
a lower probability of staying 5 or fewer days compared to patients without lung 
cancer. 
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Note that there is an intersection point of costs for patients at around 19,000, 
indicating that there is a higher probability of higher cost if the patient has lung 
cancer. From the summary table, we know that the average cost for a patient 
with lung cancer is around 26,425. 
Next, we considered the diagnosis codes and examined more in-depth the types 
of complications that patients have in relation to lung cancer. Recall that there 
are 8,216 patients with a diagnosis of lung cancer for the year 2004. Patients can 
be represented in multiple categories. Since there is no ranking between patients 
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based on claims data, text mining can be used to determine clusters and classify 
the patients in those clusters based on the conditions from the claims. Here, Text 
Miner in Enterprise Miner was used to examine the data according to text strings 
of patient conditions. In order to perform text analysis on the lung cancer data, 
the Text Miner node in Enterprise Miner was used to examine the data according 
to text strings of patient conditions defined above. Cluster analysis was used to 
find the categories of documents. To define text clusters, we limit the number of 
terms to ten to describe clusters. We use the standard defaults of Expectation 
Maximization and Singular Value Decomposition . For example, the text analysis 
defined seven different clusters in the data that were given in Table 6.3. In order 
to compare outcomes by text clusters , we merge the cluster descriptions and the 
cluster numbers into the original dataset. We use kernel density estimation to 
make a comparison of age, length of stay and cost by clusters. 
Table 6.3 Cluster table for diagnosis strings. 
1 5990,486,2859 , 25000,42731 1236 0.15043816 ... 0.1259563 ... 
2 25000,41401,4280,412,41400 938 0.11416747 ... 0.1186902 ... 
3 1629,486,4280 , 42731,2765 1666 0.20277507 ... 0.1283921 ... 
4 3051,1623,5121,496,v1582 399 0.04856377 ... 0.1100431 ... 
5 311,1972,1622, 53081,3051 1387 0.16881694 ... 0.1285800 .. . 
6 1985,2768,1628,2765,1983 1641 O. 19973222 ... 0.1242998 ... 
7 3051 , v1582, 1961 , 1625 , 49121 949 0.11550632 ... 0.1240970 .. . 
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Table 6.4 shows the translations of these clusters . These code translations are 
provided at http://icd9cm.chrisendres.com/. 
Table 6.4 Translation for the clusters 
Cluster Description Label 
# 
1 Unspecified Urinary tract infection , Pneumonia , Diabetes and 
Unspecified Anemia , Diabetes mellitus without Heart 
mention of complication , Atrial fibrillation Problems 
2 Diabetes mellitus without mention of complication , Diabetes and 
Coronary atherosclerosis, Unspecified Congestive Heart 
heart failure, Old myocardial infarction Problems 
(CHF) 
3 Unspecified Bronchus and lung, Pneumonia , COPD and 
Unspecified Congestive heart failure, Atrial fibrillation , Heart 
Volume depletion problems 
4 Tobacco use disorder, Upper lobe, bronchus or lung, COPD and 
Iatrogenic pneumothorax, Chronic airway obstruction , smoking 
History of tobacco use 
5 Depressive disorder, Pleura, Main bronchus, Depression 
Esophageal reflux, Tobacco use disorder 
6 Secondary malignant neoplasm of Bone, bone Metastasizi ng 
marrow, Brain and spinal cord , Hypopotassemia, Cancer 
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Cluster Description Label 
# 
Malignant neoplasm of Other parts of bronchus or 
lung, 
7 Tobacco use disorder, History of tobacco use, COPD and 
Secondary and unspecified malignant neoplasm of cancer in the 
Intrathoracic lymph nodes, Malignant neoplasm of lymph nodes 
Lower lobe, bronchus or lung, Chronic bronchitis With 
(acute) exacerbation 
We want to examine the relationship between lung cancer and other diseases. 
The concept links could show how different terms are related in the documents. 
Hence, we use concept links of 1620; the links for 1622, 1623,1624,1625,1628 
and 1629 are similar. 
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Figure 6.5 Concept links for 1620, Malignant Neoplasm of Trachea 
Note that most of the links are to code 1618 (shown with the widest line), 
malignant neoplasm of other specified sites of larynx. The other large links are to 
5303 (Stricture and stenosis of esophagus) , v1 011 (Personal history of malignant 
neoplasm of Bronchus and lung), and 49390 (Asthma). 
Again , kernel density estimation was use to make a comparison of age, length of 
stay and cost by clusters . The code was the following : 
data emwsl . clusternis (keep=_cluster freq __ rmsstd 
clus_desc) ; 
set emwsl . text cluster ; 
run ; 
data emwsl . desccopynis (drop=_ svd_l - _svd_50 0 
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roll 1- roll 1000 probl - prob500) ; 
set emwsl . text documents ; 
run ; 
proc sort data=emwsl . clusternis ; 
by cluster ; 
proc sort data=emwsl.desccopynis ; 
by cluster ; 
data emwsl . nistextranks ; 
merge emwsl . clusternis emwsl . desccopynis ; 
run ; 
proc kde data=emwsl . nistextranks ; 
univar totchg/gridl=O gridu=100000 
out=emwsl . kdecostbycluster ; 
by cluster ; 
run ; 
proc kde data=emwsl . nistextranks ; 
univar age/gridl=O gridu=100 
out=emwsl . kdeagebycluster ; 
by cluster ; 
run ; 
proc kde data=emwsl . nistextranks ; 
univar los/gridl=O gridu=35 
out=emwsl . kdelosbycluster ; 
by cluster ; 
run ; 
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The average cost for cluster 6 is large compared to other clusters. There is no 
big difference between clusters 1, 2, 3 and 7, which mean that they have similar 
severity conditions. Cluster 5 has a slightly higher probability of a higher cost 
than cluster 4 (Figure 6.6) . 
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Figure 6.7 Kernel Density Estimate for Age by Clusters. 
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For the average age of each cluster, note that cluster 5 has the smallest average 
age, around 61 , compared to other clusters. Clusters 1, 4 and 6 have a similar 
average age of 70. Similarly, clusters 2, 3 and 7 have an average age of 75. 











0 5 10 15 20 25 30 35 
Length of Stay 
1# - 1 - 2 - 3 - 4 5 - 6 - 7 1 
Note that cluster 6 has a higher probability of a longer stay compared to the 
others. It would seem reasonable that patients at higher risk will stay longer and 
have higher cost. 
6.4. Time Series and Forecasting 
Next, we want to investigate and forecast the total costs of treatment on lung 
cancer to determine the future costs based on the inflation rate [35] with 
consideration of the patient outcomes and conditions of the patients undergoing 
different treatments to help the hospital build a good and effective financial 
system. 
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Consider Figure 6.9, for example, which shows the trend of the total cost for lung 
cancer over the period from January, 2000 to December, 2004 with 60 monthly 
average charges. For the 4-year period , the price increases from $20,000 in 
2000 to $32,000 in 2004. Time series analysis is an appropriate method for this 
purpose. 
Figure 6.9 The trend of Total Charge from Jan 2000 to Dec 2004. 
Total Charge for Lungcancer 
TOTCHG 









01 JA N2000 01JAN200 1 0 1JAN2002 0 1JA N2003 0 1JAN 2004 0 1JAN 2005 
Date 
Time series models were also used to analyze the Total Cost, Age, Length of 
Stay and Inflation Rate. We used some time series features in Enterprise Guide 
to create time series data. Here, we accumulated using the average. After 
accumulating, the number of records decreased to 60 with the time interval of 
month . The inflation rate data over the same period were collected from the 
website, inflationrate.com, and added to those monthly average data. Different 
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models were considered with or without the inflation rate. Enterprise Guide was 
used to create a SAS dataset. Then , Time Series models were used to examine 
the data. It made the information of price more visible with respect to date. 
Figure 6.10 The plots of Total Charges by Los and Age. 
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Note that there is an increasing trend for the mean of Total charges while Length 
of stay is approximately increasing . However, this trend is not very clear when 
the number of days is between 100 and 200 because of the insufficient data in 
this study. The plot of total charge and age shows that the amount of charges of 
patients with age from 50 to 80 is much higher than those of patients with age 
less than 45. There exists some relationship between them , which is not clear 
just by the information from these graphs. 
The inflation rate was selected as a dynamic regressor, specifying a denominator 
factor with a simple order of 1, which represents a shifting of the inflation rate by 
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one time unit, implying that the inflation rate leads the total cost by one month. 
Then , Age and Length of Stay were selected as regressors to predict the total 
cost. Since the actual data are increasing as shown in Figure 6.9, we added the 
linear trend in the model. ARIMA (3, 1, 0) and ARMA (2, 1) were selected as the 
seasonal model and error model , respectively. 
We applied all possible models on the data by switching values for p and d. Also , 
other models were applied in order to choose the best fit model for the data. We 
compared all models by looking at the Root Mean Square Error and R Square. 
All these diagnostic measures show that INFLATION[/D(1)]+LOS+LlNEAR 
TREAD +AGE+ARIMA(2,0, 1 )(3, 1 ,O)s is the best model for our data. Figure 6.11 
shows the list of models used. The smallest Root Mean Square Error is 1330.8. 
Figure 6.11 Root Mean Square Error for Different Models Used 
O.t. Set : ILC.LC_TIHESERIES_F"EOOB 
S .. r I ... ' ITOTCHO : TOTCHO 
D.t. "'. n ge , IJI'INEOOO to DECeOO"l 
F"lt R.ng .. ' I JI'IN eOOO to DECeOO"l 
EV.lu.tlon R.ng .. . I JI'INeOOO to DECeOO"l 
F"ot'"'ec •• t 
HOd .. I Hod .. I Title 
1,1,1 ). 
75 
1 nterv. I : IHONTH 
Brow_e ••• I 
S .. t R.no ... ·•· I 





Figure 6.12 Prediction Error Autocorrelation Plots and White Noise 
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The autocorrelation function (ACF) was used to examine the seasonality by 
calculating and plotting the residuals, which are the difference from each data 
point to the mean. The null hypothesis for the ACF is that each time series 
observation is not correlated to others. A criterion for ACF to test the 
autocorrelation is whether there are residuals that are greater than two standard 
deviations away from the mean, then it indicates the statistically significant 
autocorrelation [36] . The partial autocorrelation function (PACF) is also used to 
detect trends and seasonality. From Figure 6.12, all ACF and PACF lags fall 
below significant levels, which means that the autocorrelation has been 
eliminated. Thus, we conclude that this model is an adequate model based on 
the white noise check, autocorrelation plot and the smallest Root Mean Square 
Error. 
Figure 6.13 The forecast of Total Cost based on ARIMA model with Regressors. 
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Note that this model fits the data well. The predicted total charges for the next 12 
months will still keep increasing, averaged at $31,500. There was a large drop at 
the end of 2004, and the predicted charge after 2004 would increase to the 
highest level, and then decrease a little. 
6.5. Logistic Regression Model for Mortality 
Lung Cancer is the leading cause of cancer deaths in the world. Therefore, it will 
be helpful for decision-making to examine the relationship between the death and 
conditions of the patients undergoing different treatments. Results show that the 
mortality of lung cancer was highly related to Age, Length of stay, 7 clusters of 
diagnosis and 9 clusters of procedures, and we also found the Logistic model for 
the mortality caused by lung cancer. 
We filtered the patients who have lung diseases using the IC09 diagnosis codes. 
We used SAS Enterprise Guide and the CATX and RXMATCH statements along 
with other functions in several lines of code to get a summary of the codes 
defining Lung cancer. After preprocessing the data, we had 8216 patient records 
involving Lung cancer for 2004. 
Regression analysis can characterize the relationship between a response 
variable and one or more predictor variables. In linear regression, the response 
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variable is continuous. In logistic regression , the response variable is categorical. 
The Log istic regression model uses the predictor variables, which can be 
categorical or continuous, to predict the probability of specific outcomes. 
Here, we focus on the relationship between Death and demographic factors such 
as Age in years at admission, financial factors such as Total charges, Median 
household income for each patient, and other clinical conditions of the patients, 
Admission type, Elective versus non-elective admission , Length of stay, MDC 
(define what MDC represents) , diagnosis and treatment procedures. Here, the 
variable, Death, was selected as the Dependent variable , and Age, Los, Totchg 
and Zipinc_qrtl were continuous variables. The Atype, Elective, MDC, Cluster of 
diagnoses and Cluster of Procedures were chosen as classification variables. 
The following table 6.5 gave us some basic information about the data for this 
study. A Logistic regression model with Fisher's scoring optimization technique 
was used to determine the relationship between those above variables. 
Table 6.5 Basic information about the data set. 
Model Information 
Data Set WORK.SORTIEMPTABLESORTED 
Response Variable Death 
Number of Response Levels 2 
Model binary logit 
Optimization Technique Fisher's scoring 
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Number of Observations Read 8216 
Number of Observations Used 5382 
Response Profile 
Ordered Total 
Value Death Frequency 
1 0 4677 
2 1 705 
Probability modeled ;s Death=O. 
Note that there were in total 8216 patient records, 705 patients who died and 
2834 records deleted due to missing values for the response or explanatory 
variables. 
We evaluated the significance of all variables in the model by using the full model 
fitted method based on the variables we discussed above. 
Table 6.6 Model fit statistics. 
Model Fit Statistics 
Intercept 
Intercept and 
Criterion Only Covariates 
AIC 4181.322 3800.647 
SC 4187.913 3945 .645 
-2 Log L 4179.322 3756.647 
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Testing Global Null Hypothesis: BETA=O 
Test Chi-Square OF Pr > ChiSq 
Likelihood Ratio 422.6752 21 <.0001 
Score 408.8682 21 <.0001 
Wald 308.3719 21 <.0001 
Max-rescaled R-Square 0.1399 
In the model fit statistics table, the various criteria (-2 Log L, AIC, SC) were 
calculated based on the likelihood for fitting a model with intercepts only and for 
fitting a model with intercepts and explanatory variables. In the Testing Global 
Null Hypothesis table to test the null hypothesis that all regression coefficients 
are zero, all three tests rejected the null hypothesis. That is, the model is not a 
constant. Here, the Max_rescaled R-square is 0.1399. 
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Table 6.7 Summary of Stepwise Selection 
Summary of Stepwise Selection 
Number Score Variable 
Effect OF In Chi-Square Pr > ChiSq Label 
Step Entered 
1 diag_cluster 6 1 159.4608 <.0001 Cluster 10 of 
diagnosis code 
2 ASOURCE 4 2 83.2749 <.0001 Admission source 
(uniform) 
3 proc_cluster 8 3 89.1558 <.0001 Cluster 10 of 
treatment 
procedures 
4 TOTCHG 1 4 53.8284 <.0001 Total charges 
(cleaned) 
5 MOC 1 5 16.7903 <.0001 MOC in effect on 
discharge date 
6 ELECTIVE 1 6 10.7637 0.0010 Elective versus non-
elective admission 
Table 6.7 listed all the variables selected by the model with the stepwise 
selection method . The diag_cluster, Asource, proc_cluster, MDe, Totchg and 
Elective are significant at the 0.05 level in the model. 
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Table 6.8 The analysis of MLEs. 
Analysis of Maximum Likelihood Estimates 
Standard Wald 
Parameter OF Estimate Error Chi-Square Pr> ChiSq 
Intercept 1 1.9357 0.3593 29.0210 <.0001 
TOTCHG 1 -6.68E-6 1.095E-6 37.2430 <.0001 
MOC 1 0 .0435 0.0105 17.2773 <.0001 
ELECTIVE 0 1 0 .2013 0.0616 10.6943 0.0011 
ASOURCE 1 1 0 .6757 0.3375 4.0089 0 .0453 
ASOURCE 2 1 -0.4618 0.3565 1.6781 0.1952 
ASOURCE 3 1 0 .0307 0.4006 0.0059 0.9390 
ASOURCE 4 1 -1.0634 1.3078 0.6611 0.4162 
diag_cluster 1 1 -0.6393 0.1041 37.6921 <.0001 
diaLciuster 2 1 0 .1405 0.1379 1.0392 0.3080 
diaLciuster 3 1 -0.6772 0.0937 52.2909 <.0001 
diaLciuster 4 1 0.7874 0.3008 6.8515 0.0089 
dial_cluster 5 1 0.4506 0.1287 12.2636 0.0005 
diaLciuster 6 1 -0.4247 0.0988 18.4727 <.0001 
proc_cluster 1 1 -0.9494 0.1257 57.0031 <.0001 
proc_cluster 2 1 -0.7141 0.1379 26.8029 <.0001 
proc_cluster 3 1 1.3825 0.6410 4.6521 0.0310 
proc_cluster 4 1 -0.7717 0.1464 27.8022 <.0001 
proc_cluster 5 1 -0.4398 0.1557 7.9757 0.0047 
proc_cluster 6 1 -0.4277 0.1895 5.0950 0.0240 
proc_cluster 7 1 0 .2403 0.3119 0.5937 0.4410 
proc_cluster 8 1 1.9703 0.4172 22.3045 <.0001 
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Since these variables are categorical , in Table 6.8, we have the regression 
coefficients for all the variables to predict the dependent variable by the 
maximum likelihood method. 
Table 6.9 The Association of Predicted Probabilities and Observed Responses 


















71.5 Somers'D 0.437 
27.9 Gamma 0.439 
0.6 Tau-a 0.099 
3297285 c 0.718 
o . 0 .,...,.. ........... 'T"T"'I'T"I""'r-r-r ........... .........,...,..,..T"T'"T'"I"'T'T"T"T""I"T"T"T'"I'"'T',..,...,'""I"T'"r-r-T"..,...,..,...,--...,,..,...,-J 
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 
1 • Specificity 
84 
Note that the area under the ROC curve is also given by the statistic c in the 
Association of Predicted Probabilities and Observed Responses table. In this 
study, the area under the ROC curve is 0.718. For model fitness, the closer the 
ROC plot is to the upper left corner (i.e. the area under the curve is close to 1), 
the more accurate of the model. However, since there are too many factors 
related to the patient's death for our study and lack of patient information, the 
logistic regression model is appropriate to predict the mortality of the lung cancer 
for this NIS database. 
6.6 Summary 
Kernel Density Estimation was used to compare graphs that can be overlaid to 
give us more information. Here, we might conclude that older patients are more 
likely to have lung cancers that would lead to a higher probability of longer stay 
and higher costs for the treatment procedure. With text analysis on the diagnosis 
codes and KDE, it shows that malignant neoplasm of lobe, bronchus or lung is of 
higher risk and has a higher cost compared to other lung cancers. 
The ARIMA model with ordinary and dynamic regressors was used to analyze the 
hospital's financial data. It provides the hospital with the ability to predict total 
charges of lung cancer based on previous costs. The ordinary and dynamic 
regressors model showed the effect of the length of stay and age on the 
predicted values of total charges. 
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Then, the Logistic model was used to examine the relationship between death 
and conditions of patients with lung diseases. In this paper, we just focused on 
Age in years at admission, Admission type, Admission source, Elective versus 
non-elective admission, Length of stay, Total charges, Median household income 
for patient MDe, and diagnosis and treatment procedures. By using the stepwise 
selection method with level 0.05, we removed Admission type, Age, LOS and 
Median household income for patient, which are not statistically significant. With 
this model, we could calculate the probability of death based on the given patient 
condition. 
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CHAPTER VII DATA ANALYSIS AND MODELING FOR MEDSTAT DATA 
7.1. MarketScan Database Overview 
The MarketScan Databases include the information about clinical utilization, 
costs, plans and membership across inpatient, outpatient, prescription drugs at 
member level and service level, which makes it possible for data analysis 
concerning outcomes. There are links between those tables such that the claims, 
drugs and patient information are on the same level. Historically, there are more 
than 500 million claims records available in the MarketScan Databases. 
The MarketScan Databases have the following tables: 
• Medical/surgical claims consisting of three tables: 
1. Inpatient Admissions Table (I) 
2. Inpatient Services Table (S) 
3. Outpatient Services Table (0) 
• Aggregated Populations Table (P) 
• Outpatient Pharmaceutical Claims Table(D) 
• Enrollment Summary Table (E) and Enrollment Detail Table (T) 
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Here we just introduce the inpatient table used in this study. 
Inpatient Admissions Table (I) 
The Inpatient Admissions Table contains the records with summarized 
information about each hospital admission case, which is combined by all of the 
associated service records. Contained in the cost information is the sum of all the 
services associated with the same admission case. The inpatient table also 
includes the principal procedure, principal diagnosis, Major Diagnostic Category 
(MDC), and Diagnosis Related Group (DRG), etc. The following table gives all 
the variables available in the admission table. We will specify those variables as 
the inputs for our analysis in later sections. 
Table 7.1. List of variables in Inpatient admission table. 
Name Long Name Name Long Name Name Long Name 
Date of 
ADMDATE Admission EESTATU Employment Status PROC2 Procedure 2 
Geographic Location 
ADMTYP Admission Type EGEOLOC Employee PROC3 Procedure 3 
Enrollee ID 
AGE AQe of Patient EIDGLAG Derivation FlaQ PROC4 Procedure 4 
AGEGRP Age Group EMPCTY County Employee PROC5 Procedure 5 
Case and Relation to 
CASEID Services Link EMPREL Employee PROC6 Procedure 6 
Zipcode Employee 3 
DATATYP Data Type EMPZIP Digit PROC7 Procedure 7 
DAYS Length of Stay ENRFLAG Enrollment Flag PROC8 Procedure 8 
Patient Birth 
DOBYR Year ENROLID Enrollee ID PROC9 Procedure 9 
Diagnosis 
DRG Related Group HOSPCTY County Hospital PROC10 Procedure 10 
Discharge 
DSTATUS Status HOSPPAY Payments Hospital PROC11 Procedure 11 
Zipcode Hospital 3 
DX1 Diagnosis 1 HOSPZIP Digit PROC12 Procedure 12 
DX2 Diagnosis 2 INDSTRY Industry PROC13 Procedure 13 
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Days from Prior 
DX3 Diagnosis 3 LASTADM Discharge PROC14 Procedure 14 
Major Diagnostic 
DX4 Diagnosis 4 MDC Category PROC15 Procedure 15 
Metropolitan 
DX5 DiagnOSis 5 MSA Statistical Area REGION Region 
Days to Next Cohort Drug 
DX6 Diagnosis 6 NEXTADM Admission RX Indicator 
Patient Indistinct Sequence 
DX? Diagnosis? PATFLAG Flag SEQNUM Number 
Gender of 
DX8 Diagnosis 8 PATID Patient ID SEX Patient 
DX9 Diagnosis 9 PDX Diagnosis Principal STATE State Hospital 
Physician Specialty Payments Net 
DX10 Diagnosis 10 PHYFLAG Coding Flag TOTNET Case 
Payments Total 
DX11 Diagnosis 11 PHYSID Physician ID TOT PAY Case 
Trim Flag 
DX12 Diagnosis 12 PHYSPAY Payments Physician TRIMLOS Length of Sta~ 
Trim Flag Per 
DX13 Diagnosis 13 PLANKEY Benefit Plan Link TRIMPDM Diem 
HospitallD 
DX14 Diagnosis 14 PLANTYP Plan Indicator UNIHOSP MDST 
DX15 Diagnosis 15 PPROC Procedure Principal VERSION Version 
MarketScan 
Employee National Weight 
EECLASS Classification PROC1 Procedure 1 WGTKEY Link 
Date Year 
YEAR Incurred 
7.2. Variables and their values 
The variable, DSTATUS, means Discharge Status, which is the status of the 
patient upon discharge from the hospital. The possible values are as follows: 
01: Discharged to home self-care 
02: Transfer to short-term hospital 
03: Transfer to SNF 
04: Transfer to ICF 
05: Transfer to other facility 
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06: Discharged home under care 
07: Left against medical advice 
08-19: Other alive status 
20-29: Died 
30-39: Not Yet dischargedlTransferred 
40-42: Other died status 
50: Discharged to home (from Hospice) 
51: Transfer to medical facility (from Hospice) 
61: Transferred to Medicare approved swing-bed 
71: Transfer/referred to other facility for outpatient services 
72: Transfer/referred to this facility for outpatient services 
99: Transfer, identified through Hospital 10 MOST change 
Missing: Invalid 
The variable DAYS means Length of Stay, which is the number of overnight 
stays for a hospital admission. 
The variable, AGEGRP, means Age Group, which is a value identifying the 







6: 65 and older 
The variable ADMTYP is Admission Type, which means the type of hospital 
admission with following values: 
1: Surgical 
2: Medical 
3: Maternity & Newborn 
4: Psych & Substance Abuse 
5: Unknown 
The variable SEX is the gender of patient with values: 
1: Male 
2: Female 
The variable, LASTADM, is the number of days between a patient's previous 
discharge and their current admission date. 
The variable, NEXTADM, is the number of days between a patient's current 
discharge and their next admission date. 
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The variable, MDC, represents the Major Diagnostic category, which is a set of 
Body-system or disease related groupings of clinical conditions, based on 
diagnosis codes. See Appendix A for the MDC values. 
The variable, REGION, is the Geographic Region of an employee's residence. 
1: Northeast 




7.3. Analysis of MarketScan Data 
We next examine the lung cancer data from the Medstat MarketScan database, 
and we used two years of data, 2000 and 2001. Each year of data included 
medical and surgical claims, aggregated populations and enrollment information. 
Here, we consider inpatient cases first. There are a total of 4,718 observations 
for two years related to lung disease out of 800,000 records. Note that 
approximately 1.05% of the inpatient population has a diagnosis of lung disease. 
First, we use PROC KDE to examine the variables in relationship to the data 
using kernel density estimation. The main advantage of using kernel density 
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estimation is that the graphs can be overlayed for more direct comparisons. For 
example, we consider the relationship of lung cancer to Age, Length of Stay and 
Costs. 
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The study was limited to The MarketScan Commercial population (who are 
covered by employer-sponsored private health insurance). Most of the members 
in this database are 65 or younger [37]. Note that the patients without lung 
diseases have a relatively constant likelihood of an inpatient event regardless of 
age (except for the interval of 0 to 20 and 60 to 80, where there is a slight change 
because of the population limitation). However, patients with lung diseases 
increase inpatient events starting at age 38, accelerating at age 45. We could not 
make any conclusions for those 65 or older because the available data contained 
only privately insured individuals instead of Medicare. 
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Those with lung diseases have a higher probability of a stay of 4 or more days, 
and a lower probability of staying 3 or fewer days compared to patients without 
lung diseases. 
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Note that there is an intersection point of costs for patients at around 7,000, 
indicating that there is a higher probability of higher cost if the patient has lung 
disease. 
Next, we considered the procedure codes and examined more in-depth the types 
of treatments that patients have in relation to lung cancer. Recall that there are 
4,718 patients with a diagnosis of lung cancer. The procedures of treatment can 
be represented in multiple categories. Here, Text Miner in Enterprise Miner was 
used to examine the data according to text strings of treatment procedures. 
Cluster analysis was used to find the categories of documents. For example, the 
text analysis defined four different clusters in the data that are given in Table 7.2. 
Table 7.2. Cluster table for procedure strings. 
99238 , 99232 , 99222 , 99231 , 71 
538 0.11403136 ... 0.09371 22 ... 020 
2 
88305 , 36620 ,88331,32480 ,88 
1263 0.26769817 ... 0.1315167 .. . 309 
3 
71260 , 99238, 99223, 99231 ,99 
2431 0.51526070 ... 0.1325482 ... 233 
4 
93320,93325,93307,93010 ,99 
486 0.10300974 .. . 0.1186490 .. . 254 
The following Table 7.3 shows the translations of these clusters by using the 
CPT codes. 
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Table 7.3 Translation for the clusters 
Cluster # Description Label 
1 Initial and subsequent hospital care, Screening by Scan 
Radiologic examination, chest, two views, (X-Ray or Other) 
frontal and lateral 
2 Level IV and VI- Surgical pathology, gross Biopsy Examination 
and microscopic examination, Pathology 
consultation during surgery; first tissue 
block, with frozen section(s), single 
specimen 
3 Initial and subsequent hospital care, MRI 
Computed tomography, thorax; with 
contrast material(s) 
4 Doppler echocardiography, Inpatient Doppler 
consultation for a new or established 
patient 
According to the results of the NIS data, cluster 6, Secondary malignant 
neoplasm of Bone, bone marrow, Brain, is related to Biopsy Examination, with a 
higher average cost. Cluster 4, COPD and smoking, are related to Screening by 
Scan (X-Ray or Other). 
Again, kernel density estimation was used to make a comparison of age, length 
of stay and cost by clusters. The average cost for cluster 2 is greater compared 
to other clusters. There is no big difference between clusters 3 and 4, which 
means that they have similar severity conditions. Cluster 1 has a slightly higher 
probability of a lower cost than other clusters (Figure 7.4). 
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For the average age of each cluster, note that all four clusters have similar 
shapes, which indicates that the average age for each cluster is 60. 
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Note that clusters 2 and 4 have a higher probability of a longer stay compared to 
the others. It would seem reasonable that patients at higher risk will stay longer 
and have higher cost. 
7.4 Medication 
The purpose of this section is to investigate top medications for lung cancer 
based on the Medstat lung cancer population. Based on the medication 
information , we examined the relationship between the medication and the 
mortality. In the Medstat database we have, the prescription data are available in 
ten different data files. We need to filter the data for the medications to study the 
treatment of lung cancer. 
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In the available data set, there are two variables specifying the drug used in the 
treatment, the NOC number (NOCNUM) and the generic product 10 (GENERIO). 
The converter for NOC numbers is available at the FDA website [38]. For each 
drug, there are multiple NOC numbers due to their dosage and type, and a few 
Generic product 10 values. Therefore, it is faster and more general to use generic 
IDs. We found the Generic IDs (names) of each drug using NOC numbers as well 
as the drug class defined. Those ten data sets were filtered by the lung cancer 
population at the beginning to reduce the process time and then were appended 
as one table at the end. 
We combined all datasets resulting from the above procedure to have one file 
containing all RX data for our study. We use programming similar to what we 
used for procedures, but this time for antibiotic so as to follow the antibiotics 
prescribed for each patient with the date. In other words, we have a one-to-many 
relationship between patients and their prescriptions. 
As a result, we have information about patients with lung cancer, including their 
procedures and prescriptions in the same dataset. In this section, we will focus 
on medication, so we only keep the drug column of the joined table with patient 
IDs. 
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Table 7.4 The top Medicines sorted by prescriptions. 
Cumulative 
Generic Name Drug Class Prescriptions Percent Percent 
Dexamethasone STEROIDS 2428 2.19 2.19 
PAIN MGMT -
Hydrocodone/Acetaminophen NARCOTIC 1806 1.63 3.82 
Levofloxacin ANTIBIOTICS 1800 1.62 5.45 
Oxycodone wI PAIN MGMT-
Acetaminophen NARCOTIC 1679 1.52 6.96 
MENTAL HEALTH 
Prochlorperazine Maleate - MISC 1631 1.47 8.44 
PAIN MGMT -
Propoxyphene-N wI APAP NARCOTIC 1397 1.26 9.7 
MENTAL HLTH -
Lorazepam ANXTY 1279 1.15 10.85 
Azithromycin ANTIBIOTICS 1200 1.08 11 .93 
Albuterollnhal Aerosol ASTHMA 1173 1.06 12.99 
Prednisone STEROIDS 1076 0.97 13.96 
Megestrol Acetate Susp CHEMOTHERAPY 1047 0.95 14.91 
Omeprazole Cap Delayed 
Release STOMACH - PPI 1036 0.94 15.84 
Famotidine STOMACH - H2 911 0.82 16.67 
Ipratropium-Albuterol Aerosol ASTHMA 862 0.78 17.45 
Cephalexin Cap ANTIBIOTICS 860 0.78 18.22 
Ciprofloxacin HCI ANTIBIOTICS 834 0.75 18.97 
Potassium Chloride NUTRITIONAL! 
Microencapsulated Crys CR VITAMIN 828 0.75 19.72 
The above top 17 medications already account for 19.72% used out of more than 
2000 medications. Below, we list some descriptions for some medications from 
the above table. 
1. Dexamethasone/ Prednisone tablets are used for the treatment of many 
different conditions, such as allergic disorders, or breathing disorders, 
which also prevent nausea and vomiting caused by the chemotherapy of 
cancer. 
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2. Hydrocodone is a narcotic pain-reliever and a cough suppressant and 
Acetaminophen is a non-narcotic analgesic (pain reliever) and antipyretic 
(fever reducer). 
3. Levofloxacin is a quinolone antibiotic used in lung or other area where 
infections are caused by certain bacteria. 
4. Oxycodone is used to treat moderate to severe pain. It is stronger than 
Hydrocodone. 
5. Prochlorperazine Maleate is used to treat severe nausea and vomiting 
from various causes such as anti-cancer treatment. 
6. Propoxyphene is a pain reliever. 
7. Lorazepam is used to reduce nervous tension. 
8. Azithromycinl Zithromax , as Levofloxacin , is used for the treatment of 
mild to moderate infections caused by certain bacteria. 
9. Inhalation Aerosol is used in chronic obstructive pulmonary disease 
(COPO), a type of lung disease leading to breathing difficulties. 
10. Megestrol Oral Suspension is used for weight loss caused by 
malignancies, systemic infections, and so on. 
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Note that the most commonly used drug classes of treatment for lung cancer are 
pain management-Narcotic, Antibiotics , Heart, Cough/Cold/Allergy, and so on. 
More details about the frequencies for each of the drug classes are listed in the 
following table. 
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Table 7.5 The frequency for each Drug class 
Drug Class Frequency 
PAIN MGMT - NARCOTIC 16047 
ANTIBIOTICS 11186 
HEART 10485 
COUGHI COLDI ALLERGY 7405 
ASTHMA 6140 
STEROIDS 6049 
STOMACHI GASTRO 5180 
MENTAL HEALTH - MISC 5073 




EYE/EAR/MOUTHfTH ROA T 2874 
STOMACH - PPI 2542 
STOMACH - H2 2211 
BLOOD THINNERS 2169 
PAIN MGMT - NON NARC 2029 
NUTRITIONAL! VITAMIN 1846 
ANTICONVULSANTS 1825 
BLOOD AGENTS 1723 
PRODUCTSI SUPPLIES 1660 
CHEMOTHERAPY 1644 
DIABETES 1532 
HORMONE THERAPY 1453 
CHOLESTEROL 1399 
PAIN MGMT - COX 2'S 1303 
MUSCLEI BONE 961 
THYROID 721 
GENITOURINARY 696 
TEST SUPPLIES 625 
OSTEOPOROSIS 320 
DIABETIC SUPPLIES 222 
IMPOTENCE 211 
MENTAL HLTHI STIMU 134 
PAIN MGMT - MIGRAINE 102 
DERMATOLOGY-ACNE 98 
MISC - NEUROLOGY 82 
IMMUNE SUPPRESSANTS 78 
CONTRACEPTIVES 50 
MISC - ENDOCRINE 19 
ANTISEPTIC SUPPLIES 13 
MISC - RESPIRATORY 12 
MISC - BIOLOGICALS 5 
ANTIDOTES 1 
MUL TIPLE SCLEROSIS 1 
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As we see, there are many patients treated with pain management and 
antibiotics, in addition to what was recommended in the literature for 
Chemotherapy. 
Next, we will examine the medication treatment for lung cancer for each record . 
However, there are multiple medication treatments for each case. Some occur 
during the inpatient period and others occur during the follow up period. Hence, 
we need to combine all the medications together that are related to the same 
case. That is, we will have one column with all the medication procedures for 
certain cases. The following codes will perform this purpose. 
proc sql ; 
create table inp sur modell as 
select distinct a . * , b . ndcnum , b . generid , b . svcdate 
from medstat . rs2 as a 
left join inp_sur_model as b 
on (a . caseid=b . caseid and a . admdate=b . admdate) ; 
quit ; 
proc sql ; 
create table ndccode as 
select distinct ndcnum 
from medstat . inp_sur_mode l l ; 
quit ; 
proc sql ; 
create able gpi as 
select distinct a . * , b . gennam 
from ndccode as a 
left join medstat . inp sur drug class as b 
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on (a . ndcnum=b . ndcnum) ; 
quit ; 
proc sql ; 
create table inp_sur mode12 as 
select distinct a . caseid , a . admdate , b . gennam 
from medstat . inp_sur_modell as a 
left join gpi as b 
on (a.ndcnum=b . ndcnum) ; 
quit ; 
proc sort data=inp_sur_mode12 ; 






var gennam ; 
by caseid admdate ; 
run ; 
label ) 
data concat_p ( keep= caseid admdate gennam ) ; 
length gennam $32000 ; 
set tran_p ; 
array rxconcat_p {*} proc : 
gennam left( trim( proc_l )) 
do i = 2 to dim( rxconcat_p ) 
gennam left( trim( gennam)) I I 
end 
run 
proc sql ; 
I I left(trim( rxconcat_p[iJ )) 





length gennam $ &gennam_LEN 
set concat_p 
run 
proc sql ; 
create table inp_sur mode13 as 
select distinct * 
from medstat . inp_sur_modell (drop=ndcnum generid svcdate) ; 
quit ; 
proc sql ; 
create table inp sur mode14 as 
sel ct distinct a . * , b . gennam 
from inp_sur_mode13 as a 
left join concat_pl as b 
on (a.caseid=b . caseid and a . admdate=b . admdate) ; 
quit ; 
Here, three medication clusters were obtained based on the medication 
procedures by using text mining techniques. The clusters are shown in Table 7.6. 
Note that the first cluster is related to Acetaminophen and Oxycodone used for 
pain reliever category. The second cluster is about the medication of 
Dexamethasone, Prochlorperazine Maleate, which is used for preventing nausea 
and vomiting caused by cancer chemotherapy. The last cluster is Morphine, 
Albuterol and Fentanyl Patch for pain relief and breathing problems. 
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Table 7.6 Clusters for medication procedures. 
sodium, delayed, mg, acetamino 
1 phen, oxycodone, wi, re lease, cr 3086 0.65132967... 0.1217083 ... 
, cap, tab 
dexamethasone, + delay, sodium 
, hydrocodone-acetaminophen, h 
2 cl, release, mg , cap, +tab , male 848 0.17897847 ... 0.1041322 ... 
ate 
su lfate, cap, soln, morphine, mc 
3 g/hr, mg, aerosol, albuterol, fenl a 804 0.16969185... 0.1328564 ... 
ny l, pal ch 
7.5. Survival Analysis 
The typical goal in survival analysis is to characterize the distribution of survival 
time for a given population, to compare th is survival time among different groups, 
or to study the relationship between the survival time and some concomitant 
variables [39]. 
The data set analyzed in this study contains the survival times of patients with 
lung cancer diagnosed. Here, the survival time is defined as the time from the 
admission date to death. The event of interest is mortality by lung cancer, and 
interest lies in whether the survival distributions differ between the different 
factors. 
Here, we define the Discharge status by using the following code. 
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data MEDSTAT . inp sur_analysis (compress=yes) ; 
set MEDSTAT . INP ADM TIME ; 
Status=O; 
if dstatus=20 or dstatus=42 then Status=l; 
else if dstatus= " then status= 2; 
else status=O; 
run ; 
Note that the patient dies if the status variable is 1. Values 0 and 2 indicate that 
the patient does not die or has a missing value, respectively. Then , we use the 
following code to generate the survival time , so that we can use survival analysis 
to examine the data . 
proc sql ; 
create table inp_sur_analysisl(compress=yes) 
as select distinct a . * , b . death_date 
from inp sur_analysis as a 
left join (select distinct caseid , admdate , max (dischgdate) as 
death_date format =mmddyy l O. O 
from inp sur_analysis 
where status=l 
group by caseid, admdate) as b 
on (a.caseid=b . caseid and a . admdate=b . admdate) ; 
quit ; 
PROC SQL ; 
CREATE TABLE MEDSTAT . inp sur analysis cluster AS SELECT distinct 
B.* , A. cluster_ 
FROM inp_sur_analysisl AS B 
INNER JOIN MEDSTAT . medtextranks AS A ON (A . caseid B. caseid) ; 
QUIT ; 
data inp_surl ; 
sa MEDSTAT . inp_sur_analysis cluster; 
if status=l then time=death date - admdate ; 
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if status ne 1 then time= '31dec2002'd-admdate ; 
run ; 
The time variable is defined as the days during which the patient was under 
observation until the event or the end of the study period , which may be either a 
death or a censoring. 
7.5.1 Kaplan-Meier method 
There are two methods to produce estimates of survival functions, the Kaplan-
Meier method and the life-table. The former is based on actual survival time, 
which is more suitable for smaller data sets with precisely measured event times 
and the latter is a time interval grouped by survival time, which is better for large 
data sets [27]. Another important advantage of the Kaplan-Meier method is that it 
considers the censored data from the sample before the event occurred. 
In our research , there are 4,718 patients with a diagnosis of lung cancer and the 
survival time is defined as the time from the admission date to death. The data 
set contains the following variables : Time, Status, Sex, Admtyp, Agegrp , Age, 
Days, Previous admission within 6 months, 4 clusters based on procedures 
codes and so on . The Time is used as survival time in days, and the Status 
variable has the value 1 for uncensored observations and 0, 2 for censored 
observations. The other variables have the values listed above. Therefore, the 
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Kaplan-Meier method and right censored method are used to examine the 
distribution of the survival time with different strata variables. 
Table 7.7 Test of Equality over Strata of Sex 
Test of Equality over Strata 
Test Chi-Square OF Pr >Chi-Square 
Log-Rank 0.9971 1 0 .3180 
Wilcoxon 0.9787 1 0.3225 
-2Log(LR) 0.8159 1 0 .3664 
This table contains rank and likelihood-based statistics for testing the 
homogeneity of survivor functions across strata . The rank tests for homogeneity 
indicate that there is no significant difference between male and female (P values 
are more than 0.3) . 
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Figure 7.8. Life Tables: Survivor Distribution Plot for Sex 
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Figure 7.7 displays the survivor function against time for each gender, where 
SDF 1 was the survivor distribution function for male and SDF 2 was the function 
for female. There is no significant difference between them at the beginning , 
which is in accord with a Test of Equality. The gap between the two curves 
distinguishes between the survivals distributions after survival time of 13, where 
the curve for Male decreases after the curve for Female. The difference in 
displayed survival curves reinforces the conclusions that female patients live 
longer than males. 
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Table 7.8. Test of Equality over Strata of Age group 
Test of Equality over Strata 
Test Chi-Square OF Pr >Chi-Square 
Log-Rank 11.9045 5 0.0361 
Wilcoxon 11.9283 5 0.0358 
-2Log(LR) 12.3412 5 0.0304 
Note that the rank tests for homogeneity indicate that the Age group is significant 
of mortality by lung cancer. 
Figure 7.9. Life Tables: Survivor Distribution Plot for Age Group 
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Note that it is clear that the six age groups were divided into two categories. 
Patients with age from 1 to 34 belong to the first category with very low mortality, 
and those with age 35 or more belong to the second category, which has a 
higher probability of death. Furthermore, the probability of survival for patients at 
age 65 or older decreases quickly from 0.888 after 10 days. 
Table 7.9. Test of Equality over Strata of Admission Type 
Test of Equality over Strata 
Test Chi-Square OF Pr >Chi-Square 
Log-Rank 68.3726 4 <.0001 
Wilcoxon 69.7864 4 <.0001 
-2Log(LR)* 83 .1681 4 <.0001 
All three tests show a significant difference between the admission types (Type 
of hospital admission: Surgical , Medical , Maternity & Newborn , Psych & 
Substance Abuse, or Unknown) (p- values are less than 0.001) . It shows that the 
admission type is an indicator for the mortality of lung cancer. From the following 
figure, we will see which admission is more closely associated with mortality. 
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Figure 7.10. Life Tables: Survivor Distribution Plot for Admission Type 
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Note that there is no death among patients registered as Maternity & Newborn 
and Psych & Substance Abuse. During the first 16 days, the probabilities of 
survival for patients registered as Surgical type and Medical type decrease to 
0.98 and 0.92, respectively. 
From what we discussed above, we defined four clusters according to the 
treatment procedure for lung cancer. They were: Cluster 1: Screening by Scan 
(X-Ray or Other) , Cluster 2: Biopsy Examination , Cluster 3: MRI and Cluster 4: 
Doppler. We examined the relationship between the treatment categories and 
mortality. First, we extracted the cluster information from the data set we used to 
define the clusters and merged it with the adjusted admission table using the 
following code. 
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PRoe SQL ; 
CREATE TABLE MEDSTAT.inp_sur_analysis_cluster AS SELECT distinct 
B. DOBYR , B. ADMDATE FORMAT=MMDDYY10 . , B . AGE , B. CASEID , B. DAYS , 
B . DRG , B. TOTNET , B. TOTPAY , B.ADMTYP , B . DSTATUS , B . PATID , B. SEX , 
B. lungcancer , B. diagnoses , B. procedures , B. AGEGRP , A. _cluster_ , 
B. time , B. status 
FROM medstat . inp_sur_analysis AS B 
INNER JOIN MEDSTAT.medtextranks AS A ON (A . caseid 
B. caseid) ; 
QUIT ; 
Table 7.10. Test of Equality over Strata of Treatment Clusters 
Test of Equality over Strata 
Test Chi-Square OF Pr >Chi-Square 
Log-Rank 66.8540 3 <.0001 
Wilcoxon 65.2475 3 <.0001 
-2Log(LR) 67.3901 3 <.0001 
Again , all three tests show a significant difference between the clusters (p-
values are less than 0.001). Different clusters are related to different mortality 
rates of lung cancer. 
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Figure 7.11. Life Tables: Survivor Distribution Plot for Treatment clusters 
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Because these clusters were based on the treatment procedures, they indicated 
the severity level of the patient condition. Note that cluster 4 has a higher 
probability of mortality than the other three clusters , with a survival rate of 0.86 at 
the first 60 days. The survival rates for clusters 1, 2 and 3 are 0.92, 0.97 and 
0.93, respectively. Furthermore, these four clusters might be divided into three 
categories. Clusters 1 and 3 have a similar survivor distribution according to 
survival time. The gaps between the categories become much clearer after 25 
days. 
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7.5.2 Cox Proportional Hazard Model [34] 
Survival analysis is appropriate for outcomes that occur during follow-up of 
patients, such as death because of cancer or recurrence of disease in cancer. In 
medical studies, the Cox proportional hazard model is the most often used 
method. 
We used the following code to create some binary variables, including Admit type, 
Region , Discharge status, and clusters of treatment procedures. 
data medstat . inp_sur ; 
set inp_surl ; typ_surg=O; typ_med=O; typ_oth= O; prev_adm_180=0; 
readm_90=0; Region_NE= O; Region_NC= O; Region_S=O; 
egion_W= O; Region_un=O; 
Dischg_home=O; dischg_transfer=O; 
dischg_died=O; dischg_oth=O; age_grpl=O; age_grp2=0; 
age_grp3=0; age_grp4=0 ; age_grp5=0; age_grp6=0; 
cluster_Screening=O; cluster_Biopsy=O; luster MRI=O; 
cluster_Doppler=O; 
cluster oth=O; 
if admtyp= ' l ' then typ_surg=l; 
else if admtyp= ' 2 , then typ_med=l; 
else typ_oth=l; 
if lastadm le 185 and lastadm gt 0 then prev_adm_180=1; 
if nextadm le 90 and nextadm gt 0 then readm 90=1; 
if region= ' l ' then region_NE=l; 
else if region= ' 2 ' then region_NC=l; 
117 
else if region= ' 3 ' then region_S=l; 
else if region= ' 4 ' then region_W=l; 
else region_un=l; 
if dstatus in ( ' 0 1 ' , ' 06 ' , ' 50 ' ) then Dischg_home=l; 
else if dstatus in 
( ' 02 ' , ' 03 ' , ' 04 ' , ' 05 ' /* , ' 51 ', ' 61 ', ' 71 ', ' 72 ', ' 99 ' */ ) then 
dischg transfer=l; 
else if dstatus in 
( ' 20 ' , ' 21 ' , ' 22 ' , ' 23 ' , ' 24 ' , ' 25 ' , ' 26 ' , ' 27 ' , ' 28 ' , ' 29 ' ) then 
dischg_died=l; 
else dischg oth=l; -
if age ge 0 and age le 17 then age grp1=1; -
else if age ge 18 and age le 34 then age grp2=1; 
else if age ge 35 and age le 44 then age grp3=1; 
else if age ge 45 and age le 54 then age grp4=1; 
else if age ge 55 and age le 64 then age grp5=1; 
-
else age grp6=1; 
if cluster =1 then cluster Screening=l; -
else if cluster =2 then cluster_Biopsy=l; 
else if cluster =3 then cluster MRI=l; 
else if cluster =4 then cluster Doppler=l; 
else cluster oth=l; 
run ; 
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Table 7.11 . Hazard ratio for the mortality of lung cancer. 
Analysis of Maximum Likelihood Estimates 
95% Hazard 
Ratio 
Parameter Standard Hazard Confidence 
Variable OF Estimate Error Chi-Square Pr > ChiSq Ratio Limits 
typ_oth 1 -12.51181 362.8222 0.0012 0.9725 0.000 0.000 2.52E30 
1 3 
typ_med 1 1.09393 0.17066 41.0861 <.0001 2.986 2.137 4.172 
typ_surg 0 0 
age.....8rpl 1 -12.75666 1520 0.0001 0.9933 0.000 0.000 
age....Brp2 1 -13.31160 401.8727 0.0011 0.9736 0.000 0 .000 
3 
age.....8rp4 1 -0.20518 0.25797 0.6326 0.4264 0.815 0.491 1.350 
age.....8rp5 1 -0.30263 0.24120 1.5742 0 .2096 0.739 0.461 1.185 
age.....8rp6 1 0.48064 0.38189 1.5840 0.2082 1.617 0.765 3.418 
age.....8rp3 0 0 
cluster_Biopsy 1 -0.33550 0.23919 1.9674 0.1607 0.715 0.447 1.143 
cluster_MRI 1 -0.20162 0 .17630 1.3078 0.2528 0 .817 0.579 1.155 
cluster_Doppler 1 0.71388 0.20039 12.6917 0.0004 2.042 1.379 3.024 
cluster_Screening 0 0 
prev_adm_180 1 -0.22023 0.16741 1.7305 0 .1883 0.802 0.578 1.114 
In the Cox proportional hazards model , the effects of the covariates are to act 
multiplicatively on the hazard of the survival time. From Output Table 7.11, the 
hazard ratio estimate for prev_adm_1BO is 0.802, meaning that the existence of 
previous admissions will shrink the hazard rate by 1-(0.802)=20%. For a CLASS 
variable parameter, the hazard ratio is the ratio of the hazard rates between the 
given category and the reference category. The hazard rate of 
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AdmitType=Medical is 299% that of AdmitType=Surgical, and the hazard rate of 
AdmitType=other is 0% that of AdmitType=Surgical. Similarly, the hazard rate of 
Cluster= Doppler is 200% that of Cluster=Screening; the hazard rate of Cluster= 
Biopsy is 72% that of Cluster=Screening and the hazard rate of Cluster= MRI is 
82% that of Cluster=Screening. 
From what we discussed above, the outcome of the Hazard Ratio analysis is 
consistent with the Kaplan-Meier method. 
7.6. Predictive Modeling 
Next, we want to estimate the probability of the occurrence of lung cancer based 
on patient age, gender, clinical conditions, days of stay and total charge by using 
modeling techniques. Since lung cancer remains a rare occurrence, we use 
stratification as the sampling method and the sample proportion is 50/50. Figure 
7.12 shows the predictive modeling process for Decision Tree, Regression and 
Neural Network in Enterprise Miner. 
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Figure 7.12. Predictive Modeling Process 
o 0 0 
o 
Comparison 
o 0 0 
Regression 
Here, the model comparison node is used to compare the results of all the 
models to determine which model gives the most accurate or least costly results . 
Table 7.12 shows the model choice using the 50/50 proportion, stratified 
sampling and the misclassification rate. 
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Table 7.12. Model Choice with Misclassification Rate 
Fit Statistics 
Model selection based on VMISC -
Train: Valid: Train: Train: Valid: 
Valid: Average Average AkaiJ1.e 's Train: Train: Valid: Kolmogorov- Kolmogorov-
Selected Kodel Kisclassification Squared Squared Information Kisclassification Roc Roc Smimov Smimov 
Kodel Node Rate. Error. Error. Criterion. Rate. Index Index Statistic Statistic 
Neural 0.49293 0.27991 0.28055 10339.33 0.49289 0.53339 ~ 0.05480 0.04523 
Reg 0.49576 0.27965 0.28138 10045.65 0.49273 0.53142 0.05268 0.04170 
Y Tree 0. 14170 0.11757 0.11134 0.15123 0.88818 0.89874 0.69755 0.71661 
Note that the Decision Tree is optimal with a 14.2% misclassification rate in the 
testing set. The ROC index for the Model Tree is 0.90 when it is 0.52 for the 
Neural Network and Regression models. Figures 7.13 and 7.14 give us the 
details of the Roc Curve and Decision Tree. 
Figure 7.13. Roc Curve for model of Lung Cancer Occurrence. 
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Figure 7.14. Decision Tree Results 
fSUU66 ---1: lUI .. " . ,... ...~ I.... • &II 
!U.t1lbC ntitllf '_11»1.1. 
I: 6C.0II 7!,~ 
0: C." U,GI 
• I~ ''*: )0 
·15 
--""-~ )I.. u,JI 
G: H." n.1\ 




,"Atlnl: i'::~ ,.Hauoo 
1: •. 2' ~'.n 
0: 63." n.n 
• 11) he: Itn 604 
I: lO,M SO,~ 
0: !O.O\ 50, ') 
lib loft: 660~ till 
.: 15 
I 
!tbusUC TtWUllf ¥tI~nuOil 
1: S9.6' S1.O, 
t: «I.~ ~.~ 
I Ulkc!t: 21S lU 
12 
I 
Sr.u.uu:. T:aiU19 'tlldl.u. bt1JtU Tt.I!I1.II; 'ui~ 
I: tl,n C.i' 1: n.1I &J._ 
J: SUt ~.~ t: li.1\ U." 
I b IG": Ul Z51 luM: Zfl III 
St.l~Jtlt Tub1tq'tl:4ttil'lD 
1: 52 ,oR 49.2\ 
I: 41.f\ 5G.~ 
I~ltoa : m 124 
t .1l 
S"'t1'U ~ i:uru.!'q rl1ldtu«I 
I: e.n U,g\ 
~: ~.n ~4,n 
I iIIlo~!: :94 10' 
Note that the Major Diagnostic Category is the first major predictor based on 
diagnosis with the Respiratory System or the Blood , Blood Forming Organs, and 
Immunological Disorders. The next split is based on the Age of the Patient at 
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39.5 years old. With these two splits, we have reached 88% of the lung cancer 
cases with 1276 records. Here, a patient more than 40 years old is at higher risk 
of lung cancer compared to those less than 40 with the same diagnosis of 
Respiratory. The decision tree clearly shows that Major Diagnostic Category, Age 
of Patient and Length of Stay are the leading predictors of lung cancer diagnosis. 
Next, we used several predictive models (Decision tree, Logistic regression and 
Neural Network) to analyze the mortality of lung cancer based on what we 
discussed above. Here, we list all the variables used in the model process as 
follows, 
1. Length of stay 
2. Age 
3. Admit type 
4. MDC code 
5. Medication treatment Clusters 
6. Previous Admission 
7. Treatment procedure Clusters 
8. Total Cost 
9. Patient location 
10. Diagnosis Clusters 
11.Gender 
12. Target variable: Death 
124 
First, we split the data into three sets with proportion of 40/30/30, training, 
validation and test sets. For the Neural network, there are three hidden units; 
multilayer preceptron architecture is used and the misclassification rate is 
selected as the model selection criteria. Also, the logistic regression model is 
used to compare with the Neural Network model. Again, the following table and 
figure show us the outcomes. 
Table 7.13 Fit statistics for model selection 
Fit Ste.tistics 
!odel selection based on JlIISC -
Train: Valid: Test: Train: 
Test: AveuQe Averaqe Aveuqe Akaike '! Train: Valid: Train: Valid: Test: 
Selected Hodel Hisclal3lfication Squmd Squmd Squmd Inforlatlon ~i!clmHicatlon HUclassificatlon Roc Roc Roc 
Model Hode Rate Erm Error Error Critmon, Rate Rate Index Index Index 
Heura12 0,066011 0,055312 0,055640 0,059416 ll24,56 0,064916 0,065441 0,79730 0,76607 0,76961 
Req2 0.066011 0,057090 0,057614 0,059712 621.16 0, 064448 0,064743 0.74936 0,13545 0.72742 
Tm2 0.0660l! 0,060294 0,060552 0,061656 0,064448 0,064743 0,50000 0,50000 0,50000 
Valid: Test: Tuin: Bin-Based Valid: Bin-Based Test: Bin-Based 
Kol1oqorov- Kolloqorov- Two-Way Two-Yay Two-hlay Train: Valld: Train: 
Slunov SlimoY Kollogorov-Saimov Kol1oqolov-Smirnov Kolloqorov-Saimov Valid: Tram: Valid: Percent Percent Capture 
StatistlC Statistic Statistic Statlstic Ste.timc Gam Lift Lift Response Response Response R 
0,42143 0,44558 0,47399 0,40909 0,42941 )79,348 4,42623 4,79346 26,5261 31.0345 22,1311 
0,40898 0,45182 0,43462 0,39156 0,43479 236,556 3,26669 3,36556 21.0531 21.1B97 16,3334 
0,00000 0,00000 0,00000 0,00000 0,00000 0,000 1,00000 1.00000 6,4446 6,4743 5,0000 
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Figure 7.15 ROC curve for model selection 
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Note that the Neural Network won this time with a testing ROC of 77%. At the 
cutoff point of 0.07, we have an overall classification rate of 72% for the test data 
set (65 true positives out of 94 positive events) . With the above 11 variables , the 
neural network model will generate a probability of mortality for each patient with 
lung cancer under different treatments. 
7. 7 Summary 
Relatively few models have been developed to estimate lung cancer risk. 
Previous lung cancer risk prediction models have tended to focus on smoking 
characteristics , sex, and age. In 2003, Peter B. Bach and Michael W. Kattan 
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developed a lung cancer risk prediction model based on the Carotene and 
Retinol Efficacy Trial (CARET), a large, randomized trial of lung cancer 
prevention. This model used smoking history data of retinol and carotene in 
heavy smokers and asbestos-exposed individuals, which was applicable to 
smokers between 50 and 75 years of age, who are or were heavy smokers (10-
60 cigarettes per day for 25 - 60 years). In 2007, to extend the work of Bach and 
Kattan and to include additional risk factors beyond smoking history and 
asbestos exposure, Margaret Spitz developed a risk prediction model for lung 
cancer using epidemiologic data for assessing lung cancer risk with a minimal 
number of risk predictors. In 2008, a logistic regression model was developed by 
Jennifer Beane and Paola Sebastiani using the biomarker, clinical factors, and 
these data combined were tested using the independent set of patients with non-
diagnostic bronchoscopies. Most of these models are constructed using smoking 
history data and clinical data to predict the occurrence of lung cancer. Our 
models are constructed based on demographic data and clinical factors, such as 
treatment procedures and medication treatments, to identify the lung cancer and 
to determine the mortality under different treatments. 
Based on text analysis on the diagnOSis codes and KDE, the relationships 
between the variables and the target, Lung Cancer, were examined. With the 
Kaplan-Meier method, Age, Admission Type and Procedure clusters are used to 
identify the significant factors for the diagnosis of Lung Cancer. The Cox Hazard 
Proportion Model yields the detail of the relationships by the hazard ratio of the 
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contribution of each variable to the target. Then, predictive modeling was used to 
investigate the rules between the variables and the target. Based on the tests 
and the ROC curve, the Decision tree is selected as the optimal model to predict 
the occurrence of lung cancer, and the Neural Network model is the optimal 
model to predict the death because of lung cancer with different treatments. 
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CHAPTER VIII CONCLUSION 
8.1 Methods Comparison 
Since the first risk predictive model for chronic disease was developed in 1976, 
many models have been developed to predict the occurrence of a disease or the 
mortality of patients. However, relatively few models have been developed to 
predict the risk of Lung Cancer in past years. Moreover, the previous predictive 
models for lung cancer focused on smoking characteristics, sex, and age. 
As far as Lung Cancer is concerned, F L Rice and R Park analyzed the relation 
between mortality from Lung Cancer and cumulative crystalline silica exposure 
with Poisson regression and Cox's proportional hazards models. In their paper, 
several model forms for Poisson regression were evaluated: Log linear, Log 
square root, Log quadratic, Power, Linear relative rate, Shape (a) and Additive 
excess rate. The Cox's hazards models were applied as alternative methods to 
examine the relationship. They got very similar results from these methods, 
which show a significant exposure-response relation between the mortality from 
Lung Cancer and the silica exposure [40]. 
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During 2002, F. D. K. Liddell and B.G. Armstrong analyzed the effects on Lung 
Cancer of cigarette smoking and exposure in Quebec Chrysotile miners and 
millers by using principal components analysis and linear and log-linear models. 
A standardized mortality ratio (SMR) was defined by the number of lung cancer 
deaths observed and the numbers of expected in the subdivision. The SMR is 
the dependent variable for the linear and log-linear models. 
In 2003, a predictive model was developed by Peter B. Bach and Michael W. 
Kattan to estimate the risk of Lung Cancer using the data from the Carotene and 
Retinol Efficacy Trial (CARET), which is a large and randomized trial of lung 
cancer prevention [2]. In their research, smoking history data of retinol and 
carotene in heavy smokers and asbestos-exposed individuals were used to train 
and validate the model that was applicable to heavy smokers at the age of 50 or 
older only. Two 1-year models were developed with similar methods and 
predictors to predict the probability of occurrence of lung cancer and the mortality 
without having been diagnosed with lung cancer. The Cox proportional hazards 
regression models were used to examine the relationship between the 
occurrence of Lung Cancer and the predictors. However, Bach's lung cancer risk 
model was only focused on seniors with a smoking history and was not able to 
distinguish the different histological types of Lung Cancer. 
Then, in 2007, to extend the work of Bach and Kattan, Margaret Spitz developed 
a risk prediction model for Lung Cancer using epidemiologic data for assessing 
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lung cancer risk with a minimal number of risk predictors [41]. In her research, 
Spitz also collected patients' demographic information, medical history (including 
physical conditions), and family history of cancer besides smoking history. In the 
article, the multivariable logistic regression model with backward selection was 
used to estimate the risk of lung cancer. The classification and regression tree 
(CART) methods were used to evaluate the higher order interactions in the 
training sets. However, the limitation for Margaret's work is that the data were 
derived from a single large case control study; that is, the case patients were 
recruited from a single tertiary cancer center and the control group was not 
population based. Then, Spitz expanded her work by adding two markers of DNA 
repair capacity in 2008. Again, multivariable logistic models were constructed to 
estimate the individual risk of Lung Cancer. As a conclusion of this article, the 
biomarker assays improved the sensitivity of the models over epidemiologic and 
clinical data only. 
Meantime, a novel data mining technique, Backward-Chaining Rule Induction 
(BCRI), was introduced by Mary E. Edgerton, Douglas H. Fisher for Gene 
Networks relevant to poor prognosis in Lung Caner. BCRI was embedded in a 
semi-supervised approach, C4.5, which is a method for learning decision trees. 
In their paper, C45W-BCRI (Wrapper-based implementation of BCRI with C4.5) 
was applied to generate the rules to estimate the long versus short survival 
periods for Lung Cancer. Seventeen rules were generated with gene interactions 
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out of 19 molecular species, and 12 were associated with Neoplasia in general 
and 5 for Lung Cancer [42]. 
In 2008, three logistic regression models were developed by Jennifer Beane and 
Paola Sebastiani using the biomarker, clinical factors, and these combined data 
were tested using the independent set of patients with non-diagnostic 
bronchoscopies [43]. The combined clinicogenomic model had better 
performance and got higher specificity and positive predictive value compared 
with the other models. 
Dursun Delen developed predictive models for survivability and variable 
explanation using Logistic Regression, Decision Trees, Artificial Neural Networks 
(ANN) and Support Vector Machines (SVMs) based on the data from the SEER 
Program of the National Cancer Institute during 2009. From their results, SVM 
models had the best performance, and the ANN models still performed better 
that other two modeling techniques [44]. 
As discussed above, several statistical model techniques were used to estimate 
the risk of Lung Cancer and smoking history was the most important predictor. 
Since the complexity of medical data, some information such as diagnosis, 
medication, or treatment procedures were not used to examine the relationship 
with the risk of Lung Cancer. 
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In this dissertation, we used Text mining to look for patterns and group patients 
with similar condition or similar treatments into the same clusters, creating new 
categorical variables for modeling. 
Medical data used in this dissertation are from a collection of claims for each 
patient. Each record includes the patient identification (Name and/or medical 
record), demographic information, clinical information, and cost information. 
Some information such as medication, diagnosis, and treatments are in textual 
format; some such as age, length of stay and costs are in numerical format. All of 
these characteristics make medical data analysis a challenging task. Krzysztof J. 
Cios and G. William Moore gave the major uniqueness of medical data in their 
article [45]. 
Medication, diagnosis, and treatments constitute the highest source of 
information about the patient in the data. Unfortunately, they cannot be used in 
the analysis as they stand. Hence, preprocessing of these variables is necessary 
to make them understandable by the models. Patients that have similar 
symptoms and diagnoses should have similar treatments, and can be grouped 
together according to these treatments. Therefore, text analysis was applied to 
allow those variables to be used with other techniques. 
We applied Text Miner with Cluster analysis to identify the claims data for Lung 
Cancer and to determine the category of diagnosis, treatment procedures and 
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medication treatments for those patients. Moreover, they were used to define 
severity level and treatment categories. Compared with using diagnosis codes 
directly, our method is more efficient and captures more useful information for 
further analysis. A decision tree was built to generate rules for identifying high 
risk lung cancer cases amongst the regular inpatient population. Decision trees 
provide interpretable decision rules and logic statements for a good 
understanding of the model. This model can then be used to predict the class to 
which an unseen object belongs by using an equivalent set of rules that are often 
easier to understand than the tree itself. 
In order to analyze the mortality of Lung Cancer, we also found that survival 
analysis is appropriate to preprocess the data for the relationship between a 
predictor variable of interest and the time of an event. The proportional hazard 
model examined the effects of different treatment clusters using the hazard ratio 
and the proportional effect of a treatment cluster (treatment procedure or 
medication treatment) that may vary with time. Several statistical models were 
developed based on demographic data and clinical factors, such as treatment 
procedures and medication treatments, to determine the mortality under different 
treatments. 
Among these techniques that were used for the analYSis of the dataset, the 
Polynomial Regression Model, Neural Network, Regression Model and Decision 
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Tree with the CHAID algorithm provided insight into the data. ROC curves were 
used to compare the performance of the models with or without diagnosis, 
medication and treatments. The models with clusters of diagnosis, medication 
and treatments generated by Text mining had better performance than the 
models excluding those variables (Figure 8.1). 
Figure 8.1 The comparison of ROC curves 
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The models with text mining clusters, polynomial regression (purple) , Neural 
network (red) and Decision Tree (light blue) , have better performance than others, 
which were the top category in the graph. The models without the cluster 
variables, polynomial regression (green) , Neural network (dark blue) and 
Decision Tree (gray) , were in the middle of the graph. From the test dataset, it 
was clear that there was a significant difference in the area under the curves. 
The following table showed the detail about the difference of the ROC index. 
Table 8.1 The ROC index for the models 
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~II Fit Statistics f:lfOI(8] 
Sel8cted Ptectecess Model Model Oescription target rreet 
Model or Node Node Variable Roc Index 
Reg3 ~eg3 Regression (Polynomial) death u.772444 
Neural2 Neural2 Neural Network (2) death 0.769813 
Reg2 Reg2 Regression (2) death 0.727424 
Tree3 Tree3 Decision Tree (CHAID) death 0.7249 
Neural3 Neural3 Neural Network (No_clusters) death 0.892801 
Reg4 Reg4 Regression (Poly_no_clusters) death 0.886578 
Tree5 Tree5 Decision Tree (CHAID NO Clusters) death 0.817125 
<l l[ ~L,}JI [>1 
The differences with regard to the cluster variables were about 9%, 7%, and 11 % 
for Polynomial regression models, Neural Network and Decision trees with the 
CHAID algorithm, respectively. The information from diagnosis, medication and 
treatments improved the predictive capability of these models. 
8.2 Conclusion 
The main aim of this dissertation was to examine the relationships between the 
patient's conditions and the outcome of Lung cancer and to develop, evaluate 
and apply specific Lung cancer risk prediction models for the prediction of the 
cost and mortality of treatment, or developing rules for identifying the diagnosis of 
Cancer, which will help clinical decision-making or reduce cost. 
Two large databases, the National Inpatient Sample for the years of 2000 to 
2004 and the Thomson MedStat MarketScan data containing all patient claims 
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for 40 million people followed for the years 2000-2001 were used to examine our 
aim. 
The Kernel Density Estimation (KDE procedure) was used to examine the 
relationships between Lung cancer and Age, Length of Stay and Total Charges 
by using data visualization. With text analysis on the diagnosis codes and KDE, it 
shows that the malignant neoplasm of lobe, bronchus or lung is of higher risk and 
has a higher cost compared to other lung cancers. 
Text mining and cluster analysis were used to reduce a large number of patient 
condition codes into cluster categories with different severity levels based on 
diagnosis codes or treatment procedure codes. These categories were used to 
examine the relationship to the costs and mortality because of cancer. 
Based on the outcomes we discussed above, a Time series model and Logistic 
Model were applied. The ARIMA model with ordinary and dynamic regressors for 
the inflation rate was used to analyze the hospital's financial data. It provides the 
hospital with the ability to predict total charges of lung cancer based on previous 
costs. The ordinary and dynamic regressors model showed the effect of the 
length of stay and age on the predicted values of total charges. 
The Logistic model was used to examine the relationship between death and 
conditions of patients with lung diseases. In this paper, we just focused on Age in 
years at admission, Admission type, Elective versus non-elective admission, 
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Length of stay, Total charges, and Median household income for patient. By 
using the backward elimination method, we removed Admission type, Elective 
versus non-elective admission and Median household income for the patient, 
which are not statistically significant. Then we refit the data with Age, Los and 
Totchg effects that are all highly statistically significant. 
With the Kaplan-Meier method, Age, Admission Type and Procedure clusters 
from the Thomson MedStat MarketScan data are significant for the diagnosis of 
Lung Cancer. The Cox Hazard Proportion Model gave us the detail of the 
relationships by hazard ratio, the contribution of each variable to the target. Then, 
predictive modeling was used to investigate the rules between the variables and 
the target. Based on the tests and ROC curve, Decision tree and Neural Network 
models are selected as the optimal model for occurrence and mortality of lung 
cancer, respectively. 
Throughout our analysis, some significant factors for lung cancer are examined 
and diagnosis cluster, treatment procedure cluster and medication cluster are 
created based on the severity level of lung cancer. Specific lung cancer risk 
prediction models based on available variables were developed, evaluated and 
used to predict the cost and mortality for the patients and to build rules for 
identifying the diagnoses of Cancer, which will help the physician's clinical 
decision making (treatment procedure and medication), to identify high-risk 
individuals and to provide better care. 
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APPENDIX A. Sample Data Elements for National Inpatient Sample (NIS) 
Database (First 8 columns out of 129). 
1 . 
,2 04200010422807 475 
1 04200010425387 75 11 416 
04200010426467 64 10 82 
04200010472184 65 8 77 
04200010474234 68 82 
04200010474754 80 10 82 
04200010476154 65 10 82 
04200010478134 69 11 96 0 
10 042000101951 42 62 1 1 
11 04200010196032 74 82 12 ' 
12 04200010199022 65 121 7 
13 04200010199432 30 
14 04200010200712 65 277 
15 04200010201492 38 296 
16 04200010211662 69 226 11 
17 04200010219822 66 11 397 2 
18 04200010221252 83 10 127 
19 0420001022241 2 58 11 82 11 
20 04200010222482 67 12 76 12 
21 0420001022441 2 74 10 296 2 
22 04200010225932 78 12 296 
21 04200010228222 80 11 
24 04200010228262 64 11 
25 04200010177287 73 2 82 13 
26 04200010177667 48 82 0 
27 04200010177727 83 419 4 
I?R nmnnJ nJ 7R1 n7 ~~ R? 1n 
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(Inpatient and Health Plan Financial Drug Enrollment 
Demographic Outpatient) Features Information Information Information 
Admission date Coordination of Total Generic Date of 
Patient ID and type benefits amount payments product ID enrollment 
Average 
Principal Deductible Net wholesale Member 
Age diagnosis code amount payments price days 
Discharge Copayment Payments Prescription Date of 
Gender status amount to physician drug payment disenrollment 
Employment 
status and Major 
classification diagnostic Payment Therapeutic 
(hourly, etc.) cateQory Plan type to hospital class 
Relationship of Principal Payments-
patient to procedure total Days 
beneficiary code admission supplied 
Secondary 
Geographic diagnosis 
location (state, codes (up to National drug 
ZIP Code) 14) code 
Secondary 
procedure 
codes (up to 
Industry 14) Refill number 
Therapeutic 
DRG group 







APPENDIX C. Sample Data Elements for Thomson MarketScan Commercial 
Database (15 Diagnosis columns out of 82) . 
5750 2888 79431 57400 5752 27801 5122 71020 
0088 78900 2765 V718 99236 
4359 436 val0 43310 43311 43330 63600 3950 
5762 7824 78900 1579 53560 5689 5778 78652 7948 43260 71020 
1623 1991 51889 7866 1622 5128 5180 78652 1629 1961 V4589 1869 32480 32486 
0539 1623 1629 99222 71010 
6826 1629 7806 VlOll 99222 71020 
53531 53501 5789 5715 4513 99222 
10 78659 78650 78651 3089 99222 71010 
11 29633 V726 2469 80050 84436 
12 5401 5409 44970 4701 
13 42781 4279 4270 78600 42789 V4501 78906 7851 4271 .33208 3783 
H 4270 78609 3734 93526 
15 5600 78903 78906 78650 5609 7510 44120 00840 
16 2189 78930 6170 58551 6829 
17 64891 650 66331 7359 59409 
18 YJOOO 99431 99433 
19 56889 2189 5680 7842 78900 V7283 2118 2182 5459 51550 
20 78659 78650 99223 71010 
21 0389 25010 4449 485 505 51881 585 78009 78609 7906 9916 44422 4599 5939 25070 31625 3808 
22 99811 57510 2851 5601 74170 88304 
23 66411 650 V270 7569 59400 
2~ 29630 30440 
25 56969 56960 9974 V442 44314 00840 




APPENDIX D. Sample Data Elements for Thomson MarketScan Commercial 
Database (15 Procedure columns out of 82) . 
63600 3950 70450 93010 71010 99222 99232 36215 36216 36217 75662 75671 75680 
43260 71020 74160 80048 80076 82140 82150 85023 85610 85730 99255 85025 99232 
32480 32486 36620 3874~ 39400 99252 01996 71010 80048 99255 71020 99233 99232 
99222 71010 99232 9923 0CQ48 
99222 71020 99232 99238 
4513 99222 99254 88305 99231 99238 
10 99222 71010 78465 99238 
11 80050 84436 84479 86592 
12 44970 4701 99254 
13 33208 3783 8951 99255 99233 99221 99232 93621 93623 00530 71010 99238 
14 3734 93526 93543 93545 93555 93556 93609 93651 99238 
15 44120 00840 4562 72194 74022 74170 88302 88307 99222 99233 99253 71020 71260 
1& 58551 6829 88305 
17 7359 59409 
18 99431 99433 
15 5459 51550 58140 71010 85025 86850 86900 86901 86922 88305 99251 99255 80049 
20 99223 71010 80049 82553 85025 93016 93018 99238 
21 31625 3808 70450 71010 88304 93010 99255 99291 99292 A0398 34201 36489 73590 
22 74170 88304 
23 7569 59400 85027 
24 
25 44314 00840 4641 
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